Diabetes Mellitus, Type 2

• 

  Subject Areas on Research

  • "Prediction is very hard, especially about the future": new biomarkers for type 2 diabetes? 
  • 2019 Update to: Management of Hyperglycemia in Type 2 Diabetes, 2018. A Consensus Report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD). 
  • 2019 update to: Management of hyperglycaemia in type 2 diabetes, 2018. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD). 
  • 30-day morbidity and mortality of sleeve gastrectomy, Roux-en-Y gastric bypass and one anastomosis gastric bypass: a propensity score-matched analysis of the GENEVA data. 
  • A Comprehensive Cardiovascular-Renal-Metabolic Risk Reduction Approach to Patients with Type 2 Diabetes Mellitus. 
  • A Crossover Design for Comparative Efficacy: A 36-Week Randomized Trial of Bevacizumab and Ranibizumab for Diabetic Macular Edema. 
  • A Low-Frequency Inactivating AKT2 Variant Enriched in the Finnish Population Is Associated With Fasting Insulin Levels and Type 2 Diabetes Risk. 
  • A Mobile Lifestyle Management Program (GlycoLeap) for People With Type 2 Diabetes: Single-Arm Feasibility Study. 
  • A Novel Mechanism for Th17 Inflammation in Human Type 2 Diabetes Mellitus. 
  • A Peer-led Diabetes Education Program in a Homeless Community to Improve Diabetes Knowledge and Empowerment. 
  • A Peripheral Blood DNA Methylation Signature of Hepatic Fat Reveals a Potential Causal Pathway for Nonalcoholic Fatty Liver Disease. 
  • A Planar Culture Model of Human Absorptive Enterocytes Reveals Metformin Increases Fatty Acid Oxidation and Export. 
  • A Single Bout of Premeal Resistance Exercise Improves Postprandial Glucose Metabolism in Obese Men with Prediabetes. 
  • A VGF-derived peptide attenuates development of type 2 diabetes via enhancement of islet β-cell survival and function. 
  • A beta cell subset with enhanced insulin secretion and glucose metabolism is reduced in type 2 diabetes. 
  • A coding and non-coding transcriptomic perspective on the genomics of human metabolic disease. 
  • A comparative analysis of Type 2 diabetes and binge eating disorder in a bariatric sample. 
  • A comparison of negative affect and disinhibited eating between children with and without parents with type 2 diabetes. 
  • A culturally targeted self-management program for African Americans with type 2 diabetes mellitus. 
  • A forecasting model of disease prevalence based on the McKendrick-von Foerster equation. 
  • A functional polymorphism in the lymphotoxin-alpha gene is associated with carotid artery wall thickness: the Diabetes Heart Study. 
  • A futile metabolic cycle activated in adipocytes by antidiabetic agents. 
  • A genetic stochastic process model for genome-wide joint analysis of biomarker dynamics and disease susceptibility with longitudinal data. 
  • A genome-wide approach accounting for body mass index identifies genetic variants influencing fasting glycemic traits and insulin resistance. 
  • A genome-wide association study identifies susceptibility variants for type 2 diabetes in Han Chinese. 
  • A genome-wide association study reveals a quantitative trait locus of adiponectin on CDH13 that predicts cardiometabolic outcomes. 
  • A genome-wide association study suggests new evidence for an association of the NADPH Oxidase 4 (NOX4) gene with severe diabetic retinopathy in type 2 diabetes. 
  • A haplotype-resolved genome assembly of the Nile rat facilitates exploration of the genetic basis of diabetes. 
  • A large sample of finnish diabetic sib-pairs reveals no evidence for a non-insulin-dependent diabetes mellitus susceptibility locus at 2qter. 
  • A large set of Finnish affected sibling pair families with type 2 diabetes suggests susceptibility loci on chromosomes 6, 11, and 14. 
  • A link between endoplasmic reticulum stress-induced β-cell apoptosis and the group VIA Ca2+-independent phospholipase A2 (iPLA2β). 
  • A longitudinal big data approach for precision health. 
  • A novel TCF7L2 type 2 diabetes SNP identified from fine mapping in African American women. 
  • A nurse-coordinated intervention for primary care patients with non-insulin-dependent diabetes mellitus: impact on glycemic control and health-related quality of life. 
  • A primer on concentrated insulins: what an internist should know. 
  • A quantitative measure of diabetes risk in community practice impacts clinical decisions: the PREVAIL initiative. 
  • A randomized intervention study to evaluate the effect of calcitriol therapy on the renin-angiotensin system in diabetes. 
  • A randomized trial comparing intravitreal triamcinolone and focal/grid photocoagulation for diabetic macular edema: baseline features. 
  • A rationally designed monomeric peptide triagonist corrects obesity and diabetes in rodents. 
  • A retrospective cohort study of economic outcomes and adherence to monotherapy with metformin, pioglitazone, or a sulfonylurea among patients with type 2 diabetes mellitus in the United States from 2003 to 2005. 
  • A review of decision aids to assess cardiovascular risk. 
  • A spreadsheet template for the analysis of optical coherence tomography in the longitudinal management of diabetic macular edema. 
  • A statistical method for region-based meta-analysis of genome-wide association studies in genetically diverse populations. 
  • A systematic assessment of cardiovascular outcomes in the saxagliptin drug development program for type 2 diabetes. 
  • A telephone-delivered intervention for patients with NIDDM. Effect on coronary risk factors. 
  • A theoretical framework for a virtual diabetes self-management community intervention. 
  • A very low-carbohydrate, low-saturated fat diet for type 2 diabetes management: a randomized trial. 
  • ACE and ACE2 activity in diabetic mice. 
  • APOE genotype is a risk factor for neuropathy severity in diabetic patients. 
  • Abdominal pain and weight loss in a patient with well controlled diabetes. 
  • Aberrant monocyte prostaglandin synthase 2 (PGS2) expression in type 1 diabetes before and after disease onset. 
  • Abnormal cardiac function in the streptozotocin-induced non-insulin-dependent diabetic rat: noninvasive assessment with doppler echocardiography and contribution of the nitric oxide pathway. 
  • Acceptability of Implantable Continuous Glucose Monitoring Sensor. 
  • Accuracy and Longevity of an Implantable Continuous Glucose Sensor in the PRECISE Study: A 180-Day, Prospective, Multicenter, Pivotal Trial. 
  • Accuracy of perceptions of overweight and relation to self-care behaviors among adolescents with type 2 diabetes and their parents. 
  • Acetaminophen normalizes glucose homeostasis in mouse models for diabetes. 
  • Acute Decompensated Heart Failure in the Setting of Acute Coronary Syndrome. 
  • Acute changes in heart rate variability in subjects with diabetes following a highway traffic exposure. 
  • Acute suppression of insulin resistance-associated hepatic miR-29 in vivo improves glycemic control in adult mice. 
  • Adaptation and testing of instruments to measure diabetes self-management in people with type 2 diabetes in mainland China. 
  • Addressing Diabetes and Poorly Controlled Hypertension: Pragmatic mHealth Self-Management Intervention. 
  • Addressing childhood overweight and obesity in the dental office: rationale and practical guidelines. 
  • Adenylosuccinate Is an Insulin Secretagogue Derived from Glucose-Induced Purine Metabolism. 
  • Adipose tissue hyaluronan production improves systemic glucose homeostasis and primes adipocytes for CL 316,243-stimulated lipolysis. 
  • African Ancestry Analysis and Admixture Genetic Mapping for Proliferative Diabetic Retinopathy in African Americans. 
  • Age-dependent impairment of glucose tolerance in the 3xTg-AD mouse model of Alzheimer's disease. 
  • Albiglutide and cardiovascular outcomes in patients with type 2 diabetes and cardiovascular disease (Harmony Outcomes): a double-blind, randomised placebo-controlled trial. 
  • Alterations of a Cellular Cholesterol Metabolism Network Are a Molecular Feature of Obesity-Related Type 2 Diabetes and Cardiovascular Disease. 
  • Alternative Dietary Patterns for Americans: Low-Carbohydrate Diets. 
  • Amylin Dyshomeostasis Hypothesis: Small Vessel-Type Ischemic Stroke in the Setting of Type-2 Diabetes. 
  • Amylin as a Potential Link between Type 2 Diabetes and Alzheimer Disease. 
  • An FTO variant is associated with Type 2 diabetes in South Asian populations after accounting for body mass index and waist circumference. 
  • An adverse lipoprotein phenotype-hypertriglyceridaemic hyperapolipoprotein B-and the long-term risk of type 2 diabetes: a prospective, longitudinal, observational cohort study. 
  • An injectable PEG-like conjugate forms a subcutaneous depot and enables sustained delivery of a peptide drug. 
  • An intracellular role for ABCG1-mediated cholesterol transport in the regulated secretory pathway of mouse pancreatic beta cells. 
  • An outcome model approach to transporting a randomized controlled trial results to a target population. 
  • Analysis of clinical predictors of kidney diseases in type 2 diabetes patients based on machine learning. 
  • Animal model for maturity-onset diabetes of the young generated by disruption of the mouse glucokinase gene. 
  • Anti-GAD antibodies in Chinese patients with youth and adult-onset IDDM and NIDDM. 
  • Antidepressant medication as a risk factor for type 2 diabetes and impaired glucose regulation: systematic review. 
  • Antidiabetic therapies affect risk of pancreatic cancer. 
  • Antihyperglycemic Therapies to Treat Patients With Heart Failure and Diabetes Mellitus. 
  • Antiplatelet Effect Durability of a Novel, 24-Hour, Extended-Release Prescription Formulation of Acetylsalicylic Acid in Patients With Type 2 Diabetes Mellitus. 
  • Antithrombotic treatment gap among patients with atrial fibrillation and type 2 diabetes. 
  • Apolipoprotein E gene polymorphisms are not associated with diabetic retinopathy: the atherosclerosis risk in communities study. 
  • Application of combined omics platforms to accelerate biomedical discovery in diabesity. 
  • Are sulfonylureas passé? 
  • Assessing electronic health record phenotypes against gold-standard diagnostic criteria for diabetes mellitus. 
  • Assessing the Effect of Personalized Diabetes Risk Assessments During Ophthalmologic Visits on Glycemic Control: A Randomized Clinical Trial. 
  • Assessing the Safety of Sitagliptin in Older Participants in the Trial Evaluating Cardiovascular Outcomes with Sitagliptin (TECOS). 
  • Assessing weight-related quality of life in obese persons with type 2 diabetes. 
  • Assessment of a patient-centered initiative to improve hypertension management for adults with comorbid type 2 diabetes at a free clinic in the rural south. 
  • Association Between Obesity and Cardiovascular Outcomes: A Systematic Review and Meta-analysis of Mendelian Randomization Studies. 
  • Association Between Perceived Barriers to Diabetes Self-management and Diabetic Retinopathy in Asian Patients With Type 2 Diabetes. 
  • Association Between Sitagliptin Use and Heart Failure Hospitalization and Related Outcomes in Type 2 Diabetes Mellitus: Secondary Analysis of a Randomized Clinical Trial. 
  • Association Between Social Determinants of Health and Glycemic Control Among African American People with Type 2 diabetes: The Jackson Heart Study. 
  • Association Between Triglycerides and Residual Cardiovascular Risk in Patients With Type 2 Diabetes Mellitus and Established Cardiovascular Disease (From the Bypass Angioplasty Revascularization Investigation 2 Diabetes [BARI 2D] Trial). 
  • Association between area-level socioeconomic status, accessibility and diabetes-related hospitalisations: a cross-sectional analysis of data from Western Victoria, Australia. 
  • Association between diabetic retinopathy and incident cognitive impairment. 
  • Association between glycated haemoglobin levels and cardiovascular outcomes in patients with type 2 diabetes and cardiovascular disease: a secondary analysis of the TECOS randomized clinical trial. 
  • Association between systolic ejection time and outcomes in heart failure by ejection fraction. 
  • Association between triclocarban and triclosan exposures and the risks of type 2 diabetes mellitus and impaired glucose tolerance in the National Health and Nutrition Examination Survey (NHANES 2013-2014). 
  • Association of Alcohol Intake With Hypertension in Type 2 Diabetes Mellitus: The ACCORD Trial. 
  • Association of DASH diet with cardiovascular risk factors in youth with diabetes mellitus: the SEARCH for Diabetes in Youth study. 
  • Association of Galectin-3 With Diabetes Mellitus in the Dallas Heart Study. 
  • Association of P-Wave Axis With Incident Atrial Fibrillation in Diabetes Mellitus (from the ACCORD Trial). 
  • Association of genetic variation in FTO with risk of obesity and type 2 diabetes with data from 96,551 East and South Asians. 
  • Association of glomerular filtration rate with outcomes of acute stroke in type 2 diabetic patients: results from the China National Stroke Registry. 
  • Association of heart rate and diabetes among 0.5 million adults in the China Kadoorie biobank: Results from observational and Mendelian randomization analyses. 
  • Association of levels of fasting glucose and insulin with rare variants at the chromosome 11p11.2-MADD locus: Cohorts for Heart and Aging Research in Genomic Epidemiology (CHARGE) Consortium Targeted Sequencing Study. 
  • Association of obesity with cardiovascular outcomes in patients with type 2 diabetes and cardiovascular disease: Insights from TECOS. 
  • Association of physical activity and air pollution exposure with the risk of type 2 diabetes: a large population-based prospective cohort study. 
  • Association of retinal arteriolar dilatation with lower verbal memory: the Edinburgh Type 2 Diabetes Study. 
  • Association of sleep and circadian patterns and genetic risk with incident type 2 diabetes: a large prospective population-based cohort study. 
  • Association study of genetic polymorphisms of SLC2A10 gene and type 2 diabetes in the Taiwanese population. 
  • Associations between complications and health-related quality of life in individuals with diabetes. 
  • Associations between metabolic syndrome and syndrome components and retinal microvascular signs in a rural Chinese population: the Handan Eye Study. 
  • Associations between β-blocker therapy and cardiovascular outcomes in patients with diabetes and established cardiovascular disease. 
  • Associations of Diabetes Genetic Risk Counseling with Incident Diabetes and Weight: 5-Year Follow-up of a Randomized Controlled Trial. 
  • Associations of intergenerational education with metabolic health in U.S. Latinos. 
  • Associations of toothbrushing behaviour with risks of vascular and nonvascular diseases in Chinese adults. 
  • Atherosclerotic disease in non-insulin-dependent diabetes mellitus: role of abnormal lipids and the place for lipid-altering therapies. 
  • Atrial Fibrillation and Diabetes Mellitus: Can We Modify Stroke Risk Through Glycemic Control? 
  • Authors' reply to "Comment on generalizability of GLP-1 RA CVOTs in US T2D population". 
  • Automated bolus advisor control and usability study (ABACUS): does use of an insulin bolus advisor improve glycaemic control in patients failing multiple daily insulin injection (MDI) therapy? [NCT01460446]. 
  • Availability and variability in guidelines on diabetic retinopathy screening in Asian countries. 
  • Avoidance of weight gain is important for oral type 2 diabetes treatments in Sweden and Germany: patient preferences. 
  • BARI 2D: A Reanalysis Focusing on Cardiovascular Events. 
  • BMI, RQ, diabetes, and sex affect the relationships between amino acids and clamp measures of insulin action in humans. 
  • Bardoxolone methyl in type 2 diabetes and stage 4 chronic kidney disease. 
  • Bariatric Surgery: A Potential Treatment for Type 2 Diabetes in Youth. 
  • Barriers to prescribing glucose-lowering therapies with cardiometabolic benefits. 
  • Baseline Characteristics of Patients With HF With Mildly Reduced and Preserved Ejection Fraction: DELIVER Trial. 
  • Baseline Characteristics of the Vitamin D and Type 2 Diabetes (D2d) Study: A Contemporary Prediabetes Cohort That Will Inform Diabetes Prevention Efforts. 
  • Baseline characteristics of patients enrolled in the Exenatide Study of Cardiovascular Event Lowering (EXSCEL). 
  • Baseline factors associated with glycaemic response to treatment with once-weekly dulaglutide in patients with type 2 diabetes. 
  • Bayesian semiparametric regression models for evaluating pathway effects on continuous and binary clinical outcomes. 
  • Be Careful What You Ask For: Effects of Benefit Descriptions on Diabetes Patients' Benefit-Risk Tradeoff Preferences. 
  • Behavioral science research in diabetes: lifestyle changes related to obesity, eating behavior, and physical activity. 
  • Benchmarking the Cost-Effectiveness of Interventions Delaying Diabetes: A Simulation Study Based on NAVIGATOR Data. 
  • Benefits of participation in diabetes group visits after trial completion. 
  • Biochemical profile of stone-forming patients with diabetes mellitus. 
  • Biomarkers: Troponin testing--risk stratification to stratified medicine. 
  • Birth cohort effects on abdominal obesity in the United States: the Silent Generation, Baby Boomers and Generation X. 
  • Birth weight is not related to risk of diabetic retinopathy in type 2 diabetes: the Atherosclerosis Risk in Communities Study. 
  • Body mass index and obesity- and diabetes-associated genotypes and risk for pancreatic cancer. 
  • Brain control of blood glucose levels: implications for the pathogenesis of type 2 diabetes. 
  • Brain insulin lowers circulating BCAA levels by inducing hepatic BCAA catabolism. 
  • Brain microvascular injury and white matter disease provoked by diabetes-associated hyperamylinemia. 
  • Branch chain amino acids: biomarkers of health and disease. 
  • Branched-Chain Amino Acids and Insulin Metabolism: The Insulin Resistance Atherosclerosis Study (IRAS). 
  • Branched-chain amino acids in disease. 
  • Bridging the integration gap between patient-generated blood glucose data and electronic health records. 
  • Bypassing the duodenum does not improve insulin resistance associated with diet-induced obesity in rodents. 
  • C-reactive protein, gamma-glutamyltransferase and type 2 diabetes in a Chinese population. 
  • CVOT Summit 2022 Report: new cardiovascular, kidney, and glycemic outcomes. 
  • Caffeine impairs glucose metabolism in type 2 diabetes. 
  • Caffeine increases ambulatory glucose and postprandial responses in coffee drinkers with type 2 diabetes. 
  • Calmodulin-induced early-onset diabetes in transgenic mice. 
  • Can We RISE to the Challenge of Youth-Onset Type 2 Diabetes? 
  • Candidate gene association study for diabetic retinopathy in persons with type 2 diabetes: the Candidate gene Association Resource (CARe). 
  • Capitalizing on prescribing pattern variation to compare medications for type 2 diabetes. 
  • Capsule Commentary on Axon et al., Differential Impact of Homelessness on Glycemic Control in Veterans with Type 2 Diabetes Mellitus. 
  • Capsule Commentary on Min et al., Comparative Effectiveness of Insulin versus Combination Sulfonylurea and Insulin: a Cohort Study of Veterans with Type 2 Diabetes: How to Escalate Therapy for Patients who Fail Sulfonylureas. 
  • Cardiac Troponin and Risk Stratification in Ischemic Heart Disease. 
  • Cardiometabolic Risk Factors among Severely Obese Children and Adolescents in the United States, 1999-2012. 
  • Cardiovascular Disease Prevention: Pharmacologic Prevention. 
  • Cardiovascular Outcome Trial Update in Diabetes: New Evidence, Remaining Questions. 
  • Cardiovascular Outcomes Trials in Type 2 Diabetes: Where Do We Go From Here? Reflections From a Diabetes Care Editors' Expert Forum. 
  • Cardiovascular and Limb Outcomes in Patients With Diabetes and Peripheral Artery Disease: The EUCLID Trial. 
  • Cardiovascular and Renal Outcomes with Efpeglenatide in Type 2 Diabetes. 
  • Cardiovascular and renal safety of metformin in patients with diabetes and moderate or severe chronic kidney disease: Observations from the EXSCEL and SAVOR-TIMI 53 cardiovascular outcomes trials. 
  • Cardiovascular outcomes with glucagon-like peptide-1 receptor agonists in patients with type 2 diabetes: a meta-analysis. 
  • Cardiovascular risk in obese diabetic patients is significantly reduced one year after gastric bypass compared to one year of diabetes support and education. 
  • Cardiovascular, mortality, and kidney outcomes with GLP-1 receptor agonists in patients with type 2 diabetes: a systematic review and meta-analysis of randomised trials. 
  • Carotid intima-media thickness progression and risk of vascular events in people with diabetes: results from the PROG-IMT collaboration. 
  • Case management of patients with Type 2 diabetes mellitus: a cross-sectional survey in Chongqing, China. 
  • Causal effects of cardiovascular risk factors on onset of major age-related diseases: A time-to-event Mendelian randomization study. 
  • Causes of Death in a Contemporary Cohort of Patients With Type 2 Diabetes and Atherosclerotic Cardiovascular Disease: Insights From the TECOS Trial. 
  • Causes of the change in the rates of mortality and severe complications of diabetes mellitus: 1992-2012. 
  • Cellular engineering and gene therapy strategies for insulin replacement in diabetes. 
  • Cellular engineering for the treatment of metabolic disorders: prospects for therapy in diabetes. 
  • Change in estimated glomerular filtration rate and fracture risk in the Action to Control Cardiovascular Risk in Diabetes Trial. 
  • Change in levels of physical activity after diagnosis of type 2 diabetes: an observational analysis from the NAVIGATOR study. 
  • Changes in depressive symptoms and glycemic control in diabetes mellitus. 
  • Changes of Circulating Irisin and High-Sensitivity C-Reactive Protein Levels in Morbidly Obese Individuals with Type 2 Diabetes After Roux-en-Y Gastric Bypass. 
  • Characteristics associated with glycemic control among family medicine patients with type 2 diabetes. 
  • Characteristics of the built environment and spatial patterning of type 2 diabetes in the urban core of Durham, North Carolina. 
  • Cholinergic augmentation of insulin release requires ankyrin-B. 
  • Chronic kidney disease in patients with non-ST-segment elevation acute coronary syndromes. 
  • Circulating markers of inflammation and endothelial function, and their relationship to diabetic retinopathy. 
  • Classically conditioned hyperglycemia in the obese mouse. 
  • Clinical Fractures Among Older Men With Diabetes Are Mediated by Diabetic Complications. 
  • Clinical Inertia in a Randomized Trial of Telemedicine-Based Chronic Disease Management: Lessons Learned. 
  • Clinical Outcomes With Metformin and Sulfonylurea Therapies Among Patients With Heart Failure and Diabetes. 
  • Clinical Outcomes in Patients With Type 2 Diabetes Mellitus and Peripheral Artery Disease: Results From the EXSCEL Trial. 
  • Clinical Outcomes of Metformin Use in Populations With Chronic Kidney Disease, Congestive Heart Failure, or Chronic Liver Disease: A Systematic Review. 
  • Clinical Phenotypes in Patients With Type 2 Diabetes Mellitus: Characteristics, Cardiovascular Outcomes and Treatment Strategies. 
  • Clinical Prediction Models for Heart Failure Hospitalization in Type 2 Diabetes: A Systematic Review and Meta-Analysis. 
  • Clinical and angiographic outcomes in diabetic patients following single or multivessel stenting in the COSTAR II randomized trial. 
  • Clinical associations of an updated medication effect score for measuring diabetes treatment intensity. 
  • Clinical correlates of tardive dyskinesia in schizophrenia: baseline data from the CATIE schizophrenia trial. 
  • Clinical factors associated with persistently poor diabetes control in the Veterans Health Administration: A nationwide cohort study. 
  • Clinical outcomes of patients with diabetes and atrial fibrillation treated with apixaban: results from the ARISTOTLE trial. 
  • Clinical progress note: Indications for and management of sodium-glucose cotransporter-2 (SGLT-2) inhibitors in hospitalized patients. 
  • Cluster Analysis of Cardiovascular Phenotypes in Patients With Type 2 Diabetes and Established Atherosclerotic Cardiovascular Disease: A Potential Approach to Precision Medicine. 
  • Co-occurring medical conditions in adults with Down syndrome: A systematic review toward the development of health care guidelines. Part II. 
  • Combination insulin and sulfonylurea therapy in insulin-requiring type 2 diabetes mellitus. 
  • Combined poor diabetes control indicators are associated with higher risks of diabetic retinopathy and macular edema than poor glycemic control alone. 
  • Comparative effectiveness and safety of medications for type 2 diabetes: an update including new drugs and 2-drug combinations. 
  • Comparing methods for performing trans-ethnic meta-analysis of genome-wide association studies. 
  • Comparing the effects of ipragliflozin versus metformin on visceral fat reduction and metabolic dysfunction in Japanese patients with type 2 diabetes treated with sitagliptin: A prospective, multicentre, open-label, blinded-endpoint, randomized controlled study (PRIME-V study). 
  • Comparison of Early Treatment Diabetic Retinopathy Study Standard 7-Field Imaging With Ultrawide-Field Imaging for Determining Severity of Diabetic Retinopathy. 
  • Comparison of Group Medical Visits Combined With Intensive Weight Management vs Group Medical Visits Alone for Glycemia in Patients With Type 2 Diabetes: A Noninferiority Randomized Clinical Trial. 
  • Comparison of Major Adverse Cardiac Events Between Instantaneous Wave-Free Ratio and Fractional Flow Reserve-Guided Strategy in Patients With or Without Type 2 Diabetes: A Secondary Analysis of a Randomized Clinical Trial. 
  • Comparison of diabetes mellitus and insulin resistance screening methods for women with polycystic ovary syndrome. 
  • Comparison of insulin glargine and liraglutide added to oral agents in patients with poorly controlled type 2 diabetes. 
  • Comparison of low- and high-carbohydrate diets for type 2 diabetes management: a randomized trial. 
  • Comparison of sodium-glucose cotransporter-2 inhibitors and thiazolidinediones for management of non-alcoholic fatty liver disease: A systematic review and meta-analysis. 
  • Comparison of time-domain OCT and fundus photographic assessments of retinal thickening in eyes with diabetic macular edema. 
  • Competing Risk of Death With End-Stage Renal Disease in Diabetic Kidney Disease. 
  • Confirmatory psychometric evaluations of the Impact of Weight on Quality of Life-Lite Clinical Trials Version (IWQOL-Lite-CT). 
  • Confirming the Bidirectional Nature of the Association Between Severe Hypoglycemic and Cardiovascular Events in Type 2 Diabetes: Insights From EXSCEL. 
  • Contemporary Medical Therapies for Patients with Peripheral Artery Disease and Concomitant Type 2 Diabetes Mellitus: a Review of Current Evidence. 
  • Continuous glucose monitors. A GPS for blood sugar control? 
  • Controlled release of biologics for the treatment of type 2 diabetes. 
  • Controversial Issues: When the drugs don't work, can surgery provide a different outcome for diabetic adolescents? 
  • Coordinated Care to Optimize Cardiovascular Preventive Therapies in Type 2 Diabetes: A Randomized Clinical Trial. 
  • Coordinating Cardiology clinics randomized trial of interventions to improve outcomes (COORDINATE) - Diabetes: rationale and design. 
  • Coping as a mediator in the relationships of spiritual well-being to mental health in black women with type 2 diabetes. 
  • Correlates of health-related quality of life in overweight and obese adults with type 2 diabetes. 
  • Correlation between retinal oscillatory potentials and retinal vascular caliber in type 2 diabetes. 
  • Correlation of light-flicker-induced retinal vasodilation and retinal vascular caliber measurements in diabetes. 
  • Cost-effectiveness and net benefit of enhanced treatment of depression for older adults with diabetes and depression. 
  • Cost-effectiveness of a National Telemedicine Diabetic Retinopathy Screening Program in Singapore. 
  • Cost-effectiveness of diabetes treatment sequences to inform step therapy policies. 
  • Creating a sustainable collaborative consumer health application for chronic disease self-management. 
  • Cross-Validating a Structural Model of Factors Influencing Diabetes Self-Management in Chinese Americans with Type 2 Diabetes. 
  • Cross-sectional and prospective study of lung function in adults with type 2 diabetes: the Atherosclerosis Risk in Communities (ARIC) study. 
  • Cultural and Social Challenges of Diabetes Self-Management Education Through Physicians' Voices. 
  • Cumulative incidence and risk factors of prediabetes and type 2 diabetes in a Singaporean Malay cohort. 
  • Current cardiovascular outcomes trials in type 2 diabetes: Perspectives and insight. 
  • Current epidemiology of diabetic retinopathy and diabetic macular edema. 
  • DCRM Multispecialty Practice Recommendations for the management of diabetes, cardiorenal, and metabolic diseases. 
  • DIFFERENCES IN ACHIEVING HBA1C GOALS AMONG PATIENTS SEEN BY ENDOCRINOLOGISTS AND PRIMARY CARE PROVIDERS. 
  • DIRECT new treatments for diabetic retinopathy. 
  • Daily Step Counts for Measuring Physical Activity Exposure and Its Relation to Health. 
  • Dapagliflozin Effects on Biomarkers, Symptoms, and Functional Status in Patients With Heart Failure With Reduced Ejection Fraction: The DEFINE-HF Trial. 
  • Dapagliflozin across the range of ejection fraction in patients with heart failure: a patient-level, pooled meta-analysis of DAPA-HF and DELIVER. 
  • Dapagliflozin and Cardiovascular Outcomes in Type 2 Diabetes. 
  • Dapagliflozin in Heart Failure with Mildly Reduced or Preserved Ejection Fraction. 
  • Dapagliflozin in heart failure with preserved and mildly reduced ejection fraction: rationale and design of the DELIVER trial. 
  • Defective glucose-stimulated insulin release from perifused islets of C57BL/6J mice. 
  • Deintensification of Treatment With Sulfonylurea and Insulin After Severe Hypoglycemia Among Older Adults With Diabetes. 
  • Delayed fracture healing and increased callus adiposity in a C57BL/6J murine model of obesity-associated type 2 diabetes mellitus. 
  • Delivering on the Promise of Technology to Augment Behavioral Interventions in Type 2 Diabetes. 
  • Depletion of circulating progenitor cells precedes overt diabetes: a substudy from the VA enhanced fitness trial. 
  • Depressed mood is a factor in glycemic control in type 1 diabetes. 
  • Depression in persons with diabetes by age and antidiabetic treatment: a cross-sectional analysis with data from the Hordaland Health Study. 
  • Design and rationale of the Utah obesity study. A study to assess morbidity following gastric bypass surgery. 
  • Design of the COmbinatioN effect of FInerenone anD EmpaglifloziN in participants with chronic kidney disease and type 2 diabetes using a UACR Endpoint study (CONFIDENCE). 
  • Design, recruitment, and baseline characteristics of the EMPA-KIDNEY trial. 
  • Detection of genetic loci associated with plasma fetuin-A: a meta-analysis of genome-wide association studies from the CHARGE Consortium. 
  • Determinants of successful glycemic control among participants in the BARI 2D trial: a post-hoc analysis. 
  • Determination of fasiglifam-induced liver toxicity: Insights from the data monitoring committee of the fasiglifam clinical trials program. 
  • Developing a toolkit for implementing evidence-based guidelines to manage hypertension and diabetes in Cambodia: a descriptive case study. 
  • Development and validation of a model to predict cardiovascular death, nonfatal myocardial infarction, or nonfatal stroke in patients with type 2 diabetes mellitus and established atherosclerotic cardiovascular disease. 
  • Development of a clinical trials version of the Impact of Weight on Quality of Life-Lite questionnaire (IWQOL-Lite Clinical Trials Version): results from two qualitative studies. 
  • Diabetes Learning in Virtual Environments: Testing the Efficacy of Self-Management Training and Support in Virtual Environments (Randomized Controlled Trial Protocol). 
  • Diabetes Medication Changes in Older Adults With Type 2 Diabetes: Insights Into Physician Factors and Questions Ahead. 
  • Diabetes Prevention Program Translation in the Veterans Health Administration. 
  • Diabetes Self-management Quality Improvement Initiative for Medically Underserved Patients. 
  • Diabetes and early postoperative outcomes following lumbar fusion. 
  • Diabetes in pregnancy. 
  • Diabetes incidence and prevalence in Hong Kong, China during 2006-2014. 
  • Diabetes medication regimens and patient clinical characteristics in the national patient-centered clinical research network, PCORnet. 
  • Diabetes mellitus and advanced liver fibrosis are risk factors for severe anaemia during telaprevir-based triple therapy. 
  • Diabetes on a cardiovascular ward: adherence to current recommendations. 
  • Diabetes status differentiates endothelial function and plasma nitrite response to exercise stress in peripheral arterial disease following supervised training. 
  • Diabetes, Pancreatogenic Diabetes, and Pancreatic Cancer. 
  • Diabetes, metabolic comorbidities, and risk of hepatocellular carcinoma: Results from two prospective cohort studies. 
  • Diabetes-specific emotional distress among African Americans and Hispanics with type 2 diabetes. 
  • Diabetes: The good in fat. 
  • Diabetic kidney disease: a report from an ADA Consensus Conference. 
  • Diabetic kidney disease: a report from an ADA Consensus Conference. 
  • Diabetic macular ischaemia is associated with narrower retinal arterioles in patients with type 2 diabetes. 
  • Diabetic microcirculatory disturbances and pathologic erythropoiesis are provoked by deposition of amyloid-forming amylin in red blood cells and capillaries. 
  • Diabetic nephropathy: of mice and men. 
  • Diabetic retinopathy and risk of heart failure. 
  • Diabetic retinopathy and the risk of coronary heart disease: the Atherosclerosis Risk in Communities Study. 
  • Diabetic retinopathy in 2011: further insights from new epidemiological studies and clinical trials. 
  • Diabetic retinopathy is associated with an increased incidence of cardiovascular events in Type 2 diabetic patients. 
  • Diabetic retinopathy is related to both endothelium-dependent and -independent responses of skin microvascular flow. 
  • Diabetic retinopathy: global prevalence, major risk factors, screening practices and public health challenges: a review. 
  • Diagnostic criteria for the diagnosis of type 2 diabetes: Discordance of multiple measures. 
  • Diet, exercise and behavioural intervention: the nonpharmacological approach. 
  • Diet-induced type II diabetes in C57BL/6J mice. 
  • Dietary and nutritional approaches for prevention and management of type 2 diabetes. 
  • Dietary carbohydrate restriction as the first approach in diabetes management: critical review and evidence base. 
  • Dietary intakes of nutrients thought to modify cardiovascular risk from three groups of American Indians: The Strong Heart Dietary Study, Phase II. 
  • Differential association of serum lipids with diabetic retinopathy and diabetic macular edema. 
  • Differential effect of body mass index on the incidence of diabetes and diabetic retinopathy in two Asian populations. 
  • Differential effects of acute and extended infusions of glucagon-like peptide-1 on first- and second-phase insulin secretion in diabetic and nondiabetic humans. 
  • Differential metabolic impact of gastric bypass surgery versus dietary intervention in obese diabetic subjects despite identical weight loss. 
  • Digital Phenotyping Self-Monitoring Behaviors for Individuals With Type 2 Diabetes Mellitus: Observational Study Using Latent Class Growth Analysis. 
  • Dipeptidyl-peptidase-4 inhibitors and pancreatic cancer: a cohort study. 
  • Dipyridamole myocardial SPECT with low heart rate response indicates cardiac autonomic dysfunction in patients with diabetes. 
  • Discovery of 318 new risk loci for type 2 diabetes and related vascular outcomes among 1.4 million participants in a multi-ancestry meta-analysis. 
  • Discovery of a class of endogenous mammalian lipids with anti-diabetic and anti-inflammatory effects. 
  • Disease management status: a typology of Latino and Euro-American patients with type 2 diabetes. 
  • Diurnal variation in retinal thickening measurement by optical coherence tomography in center-involved diabetic macular edema. 
  • Do diabetic veterans use the Internet? Self-reported usage, skills, and interest in using My HealtheVet Web portal. 
  • Does Type 2 Diabetes Genetic Testing and Counseling Reduce Modifiable Risk Factors? A Randomized Controlled Trial of Veterans. 
  • Does the presence of a pharmacist in primary care clinics improve diabetes medication adherence? 
  • Duodenal-jejunal exclusion improves glucose tolerance in the diabetic, Goto-Kakizaki rat by a GLP-1 receptor-mediated mechanism. 
  • Duration of type 2 diabetes does not appear to moderate hypoglycaemia rate with insulin degludec versus insulin glargine U100. 
  • Effect of Linagliptin vs Placebo on Major Cardiovascular Events in Adults With Type 2 Diabetes and High Cardiovascular and Renal Risk: The CARMELINA Randomized Clinical Trial. 
  • Effect of Once-Weekly Exenatide in Patients With Type 2 Diabetes Mellitus With and Without Heart Failure and Heart Failure-Related Outcomes: Insights From the EXSCEL Trial. 
  • Effect of Once-Weekly Exenatide on Clinical Outcomes According to Baseline Risk in Patients With Type 2 Diabetes Mellitus: Insights From the EXSCEL Trial. 
  • Effect of SGLT2 Inhibitors on Stroke and Atrial Fibrillation in Diabetic Kidney Disease: Results From the CREDENCE Trial and Meta-Analysis. 
  • Effect of Sitagliptin on Cardiovascular Outcomes in Type 2 Diabetes. 
  • Effect of Sitagliptin on Kidney Function and Respective Cardiovascular Outcomes in Type 2 Diabetes: Outcomes From TECOS. 
  • Effect of Sotagliflozin on Total Hospitalizations in Patients With Type 2 Diabetes and Worsening Heart Failure : A Randomized Trial. 
  • Effect of Vitamin D Supplementation on Kidney Function in Adults with Prediabetes: A Secondary Analysis of a Randomized Trial. 
  • Effect of a 12-month intensive lifestyle intervention on hepatic steatosis in adults with type 2 diabetes. 
  • Effect of a Comprehensive Telehealth Intervention vs Telemonitoring and Care Coordination in Patients With Persistently Poor Type 2 Diabetes Control: A Randomized Clinical Trial. 
  • Effect of a group medical clinic for veterans with diabetes on body mass index. 
  • Effect of a telemedicine intervention for diabetes-related foot ulcers on health, well-being and quality of life: secondary outcomes from a cluster randomized controlled trial (DiaFOTo). 
  • Effect of endogenous GLP-1 on insulin secretion in type 2 diabetes. 
  • Effect of ezetimibe/simvastatin compared with atorvastatin on lipoprotein subclasses in patients with type 2 diabetes and hypercholesterolaemia. 
  • Effect of genetic testing for risk of type 2 diabetes mellitus on health behaviors and outcomes: study rationale, development and design. 
  • Effect of once-weekly exenatide on estimated glomerular filtration rate slope depends on baseline renal risk: A post hoc analysis of the EXSCEL trial. 
  • Effect of once-weekly exenatide on hospitalization for acute coronary syndrome or coronary revascularization in patients with type 2 diabetes mellitus. 
  • Effect of race on cardiometabolic responses to once-weekly exenatide: insights from the Exenatide Study of Cardiovascular Event Lowering (EXSCEL). 
  • Effect of race on the glycaemic response to sitagliptin: Insights from the Trial Evaluating Cardiovascular Outcomes with Sitagliptin (TECOS). 
  • Effect of sodium-glucose cotransporter 2 inhibitors on cardiovascular and kidney outcomes-Systematic review and meta-analysis of randomized placebo-controlled trials. 
  • Effect of vitamin D supplementation on cardiovascular risk in type 2 diabetes. 
  • Effectiveness of laparoscopic Roux-en-Y gastric bypass on obese class I type 2 diabetes mellitus patients. 
  • Effects of Dapagliflozin According to the Heart Failure Collaboratory Medical Therapy Score: Insights From DAPA-HF. 
  • Effects of ECT on diabetes mellitus. An attempt to account for conflicting data. 
  • Effects of Linagliptin on Cardiovascular and Kidney Outcomes in People With Normal and Reduced Kidney Function: Secondary Analysis of the CARMELINA Randomized Trial. 
  • Effects of Liraglutide on Cardiovascular Outcomes in Type 2 Diabetes Patients With and Without Baseline Metformin Use: Post Hoc Analyses of the LEADER Trial. 
  • Effects of Liraglutide on Clinical Stability Among Patients With Advanced Heart Failure and Reduced Ejection Fraction: A Randomized Clinical Trial. 
  • Effects of Once-Weekly Exenatide on Cardiovascular Outcomes in Type 2 Diabetes. 
  • Effects of Roux-en-Y Gastric Bypass on Osteoclast Activity and Bone Density in Morbidly Obese Patients with Type 2 Diabetes. 
  • Effects of Roux-en-Y gastric bypass or diabetes support and education on insulin sensitivity and insulin secretion in morbidly obese patients with type 2 diabetes. 
  • Effects of SGLT2 inhibitor dapagliflozin in patients with type 2 diabetes on skeletal muscle cellular metabolism. 
  • Effects of Selonsertib in Patients with Diabetic Kidney Disease. 
  • Effects of Tirzepatide, a Dual GIP and GLP-1 RA, on Lipid and Metabolite Profiles in Subjects With Type 2 Diabetes. 
  • Effects of Vitamin D Supplementation on Insulin Sensitivity and Secretion in Prediabetes. 
  • Effects of a health education program to promote healthy lifestyle and glycemic control in patients with type 2 diabetes: A randomized controlled trial. 
  • Effects of an energy-restricted low-carbohydrate, high unsaturated fat/low saturated fat diet versus a high-carbohydrate, low-fat diet in type 2 diabetes: A 2-year randomized clinical trial. 
  • Effects of candesartan on the development of a new diagnosis of diabetes mellitus in patients with heart failure. 
  • Effects of exenatide and open-label SGLT2 inhibitor treatment, given in parallel or sequentially, on mortality and cardiovascular and renal outcomes in type 2 diabetes: insights from the EXSCEL trial. 
  • Effects of exercise training alone vs a combined exercise and nutritional lifestyle intervention on glucose homeostasis in prediabetic individuals: a randomised controlled trial. 
  • Effects of glucagon like peptide-1 to mediate glycemic effects of weight loss surgery. 
  • Effects of hybrid comprehensive telerehabilitation on cardiopulmonary capacity in heart failure patients depending on diabetes mellitus: subanalysis of the TELEREH-HF randomized clinical trial. 
  • Effects of intensive glucose lowering in type 2 diabetes. 
  • Effects of ipragliflozin versus metformin in combination with sitagliptin on bone and muscle in Japanese patients with type 2 diabetes mellitus: Subanalysis of a prospective, randomized, controlled study (PRIME-V study). 
  • Effects of potassium supplements on glucose metabolism in African Americans with prediabetes: a pilot trial. 
  • Effects of relaxation therapy on patients with type I diabetes mellitus. 
  • Effects of short-term very low-calorie diet on intramyocellular lipid and insulin sensitivity in nondiabetic and type 2 diabetic subjects. 
  • Effects of sodium-glucose cotransporter 1 and 2 inhibitors on cardiovascular and kidney outcomes in type 2 diabetes: A meta-analysis update. 
  • Efficacy and Safety of the Glucagon Receptor Antagonist RVT-1502 in Type 2 Diabetes Uncontrolled on Metformin Monotherapy: A 12-Week Dose-Ranging Study. 
  • Efficacy and safety of SGLT2 inhibitors in heart failure: systematic review and meta-analysis. 
  • Efficacy and safety of acarbose in metformin-treated patients with type 2 diabetes. 
  • Efficacy and safety of dapagliflozin in acute heart failure: Rationale and design of the DICTATE-AHF trial. 
  • Efficacy and safety of dapagliflozin in patients with heart failure with mildly reduced or preserved ejection fraction by baseline glycaemic status (DELIVER): a subgroup analysis from an international, multicentre, double-blind, randomised, placebo-controlled trial. 
  • Efficacy and safety of sodium-glucose cotransporter 2 inhibitors initiation in patients with acute heart failure, with and without type 2 diabetes: a systematic review and meta-analysis. 
  • Efficacy of alogliptin, a dipeptidyl peptidase-4 inhibitor, on glucose parameters, the activity of the advanced glycation end product (AGE) - receptor for AGE (RAGE) axis and albuminuria in Japanese type 2 diabetes. 
  • Efficacy of metformin and fermentable fiber combination therapy in adolescents with severe obesity and insulin resistance: study protocol for a double-blind randomized controlled trial. 
  • Efpeglenatide and Clinical Outcomes With and Without Concomitant Sodium-Glucose Cotransporter-2 Inhibition Use in Type 2 Diabetes: Exploratory Analysis of the AMPLITUDE-O Trial. 
  • Egg Consumption and Risk of Total and Cause-Specific Mortality: An Individual-Based Cohort Study and Pooling Prospective Studies on Behalf of the Lipid and Blood Pressure Meta-analysis Collaboration (LBPMC) Group. 
  • Elevated prothrombin level and shortened clotting times in subjects with type 2 diabetes. 
  • Elevated resistin levels induce central leptin resistance and increased atherosclerotic progression in mice. 
  • Eligibility of sodium-glucose co-transporter-2 inhibitors among patients with diabetes mellitus admitted for heart failure. 
  • Eligibility varies among the 4 sodium-glucose cotransporter-2 inhibitor cardiovascular outcomes trials: implications for the general type 2 diabetes US population. 
  • Empagliflozin for Heart Failure With Preserved Left Ventricular Ejection Fraction With and Without Diabetes. 
  • Empagliflozin in Patients with Chronic Kidney Disease. 
  • Empagliflozin in patients post myocardial infarction rationale and design of the EMPACT-MI trial. 
  • Enteroinsular signaling: perspectives on the role of the gastrointestinal hormones glucagon-like peptide 1 and glucose-dependent insulinotropic polypeptide in normal and abnormal glucose metabolism. 
  • Erosive Esophagitis and Symptoms of Gastroesophageal Reflux Disease in Patients with Morbid Obesity with and without Type 2 Diabetes: a Cross-sectional Study. 
  • Establishing an electronic health record-supported approach for outreach to and recruitment of persons at high risk of type 2 diabetes in clinical trials: The vitamin D and type 2 diabetes (D2d) study experience. 
  • Estimated Long-Term Benefit of Dapagliflozin in Patients With Heart Failure. 
  • Ethnic identity and type 2 diabetes health attitudes in Americans of African ancestry. 
  • Etiology of Persistent Microalbuminuria in Nigeria (P_MICRO study): protocol and study design. 
  • Evaluating Natural Experiments that Impact the Diabetes Epidemic: an Introduction to the NEXT-D3 Network. 
  • Evaluating diabetes health policies using natural experiments: the natural experiments for translation in diabetes study. 
  • Evaluating the precision of EBF1 SNP x stress interaction association: sex, race, and age differences in a big harmonized data set of 28,026 participants. 
  • Evidence for a metabolic mechanism in the improvement of type 2 diabetes after sleeve gastrectomy in a rodent model. 
  • Evidence of early retinal microvascular changes in patients with type 2 diabetes and depression. 
  • Evidence that down-regulation of beta-cell glucose transporters in non-insulin-dependent diabetes may be the cause of diabetic hyperglycemia. 
  • Exaggeration of postprandial hyperglycemia in patients with type 2 diabetes by administration of caffeine in coffee. 
  • Examining the heterogeneity inexcess risks of coronary heart disease, stroke, dialysis, and lower extremity amputation associated with type 2 diabetes mellitus across demographic subgroups in an Asian population: A population-based matched cohort study. 
  • Examining the impact of genetic testing for type 2 diabetes on health behaviors: study protocol for a randomized controlled trial. 
  • Exenatide Protects Against Glucose- and Lipid-Induced Endothelial Dysfunction: Evidence for Direct Vasodilation Effect of GLP-1 Receptor Agonists in Humans. 
  • Exenatide and rimonabant: new treatments that may be useful in the management of diabetes and obesity. 
  • Exercise and atherosclerotic heart disease in women. 
  • Exercise maintains euglycemia in association with decreased activation of c-Jun NH2-terminal kinase and serine phosphorylation of IRS-1 in the liver of ZDF rats. 
  • Exercise training for diabetes: the "strength" of the evidence. 
  • Exploring the Possible Impact of Unbalanced Open-Label Drop-In of Glucose-Lowering Medications on EXSCEL Outcomes. 
  • Exploring the Relationship Between Efpeglenatide Dose and Cardiovascular Outcomes in Type 2 Diabetes: Insights From the AMPLITUDE-O Trial. 
  • External applicability of the Effect of ticagrelor on Health Outcomes in diabEtes Mellitus patients Intervention Study (THEMIS) trial: An analysis of patients with diabetes and coronary artery disease in the REduction of Atherothrombosis for Continued Health (REACH) registry. 
  • Ezetimibe/simvastatin vs atorvastatin in patients with type 2 diabetes mellitus and hypercholesterolemia: the VYTAL study. 
  • FGF21-FGFR4 signaling in cardiac myocytes promotes concentric cardiac hypertrophy in mouse models of diabetes. 
  • FPIN's clinical inquiries. Angiotensin blockade in patients with diabetic nephropathy. 
  • FTO variants are associated with obesity in the Chinese and Malay populations in Singapore. 
  • Factors associated with non-adherence to insulin and non-insulin medications in patients with poorly controlled diabetes. 
  • Factors associated with persistent poorly controlled diabetes mellitus: clues to improving management in patients with resistant poor control. 
  • Factors influencing diabetes self-management in Chinese people with type 2 diabetes. 
  • Factors influencing longitudinal changes of circulating liver enzyme concentrations in subjects randomized to placebo in four clinical trials. 
  • Failure of genetically selected miniature swine to model NIDDM. 
  • Familiality of quantitative metabolic traits in Finnish families with non-insulin-dependent diabetes mellitus. Finland-United States Investigation of NIDDM Genetics (FUSION) Study investigators. 
  • Family PArtners in Lifestyle Support (PALS): Family-based weight loss for African American adults with type 2 diabetes. 
  • Family diabetes matters: a view from the other side. 
  • Family predictors of disease management over one year in Latino and European American patients with type 2 diabetes. 
  • Fasting and postprandial concentrations of somatostatin-28 and somatostatin-14 in type II diabetes in men. 
  • Fat hormones pull their weight in the CNS. 
  • Fat, carbohydrate, and calories in the development of diabetes and obesity in the C57BL/6J mouse. 
  • Fenofibrate - a potential systemic treatment for diabetic retinopathy? 
  • Fenofibrate: a new treatment for diabetic retinopathy. Molecular mechanisms and future perspectives. 
  • Fiber cell morphology and cytoplasmic texture in cataractous and normal human lens nuclei. 
  • Fibrate use in the United States and Canada. 
  • Fibroblast growth factor 21 mediates specific glucagon actions. 
  • Fibroblast growth factor 23 and incident CKD in type 2 diabetes. 
  • Finerenone in patients with chronic kidney disease and type 2 diabetes with and without heart failure: a prespecified subgroup analysis of the FIDELIO-DKD trial. 
  • First-trimester C-reactive protein and subsequent gestational diabetes. 
  • Five-Year Outcomes After Vertical Sleeve Gastrectomy for Severe Obesity: A Prospective Cohort Study. 
  • Flicker light-induced retinal vasodilation in diabetes and diabetic retinopathy. 
  • Frequency and risk factors of non-retinopathy ocular conditions in people with diabetes: the Singapore Malay Eye Study. 
  • Frequency of abnormal carbohydrate metabolism and diabetes in a population-based screening of adolescents. 
  • Functional Impairments Mediate Association Between Clinical Fracture Risk and Type 2 Diabetes Mellitus in Older Women. 
  • Further ex vivo evidence supporting higher aspirin dosing in patients with coronary artery disease and diabetes. 
  • GIP mediates the incretin effect and glucose tolerance by dual actions on α cells and β cells. 
  • GLP-1 Receptor Blockade Reduces Stimulated Insulin Secretion in Fasted Subjects With Low Circulating GLP-1. 
  • GLP-1 and energy balance: an integrated model of short-term and long-term control. 
  • Galphaz negatively regulates insulin secretion and glucose clearance. 
  • Gaps in Evidence-Based Therapy Use in Insured Patients in the United States With Type 2 Diabetes Mellitus and Atherosclerotic Cardiovascular Disease. 
  • Gastric Bypass Surgery Leads to Long-term Remission or Improvement of Type 2 Diabetes and Significant Decrease of Microvascular and Macrovascular Complications. 
  • Gastric bypass significantly improves quality of life in morbidly obese patients with type 2 diabetes. 
  • Gastric bypass surgery restores meal stimulation of the anorexigenic gut hormones glucagon-like peptide-1 and peptide YY independently of caloric restriction. 
  • General Behavioral Engagement and Changes in Clinical and Cognitive Outcomes of Patients with Type 2 Diabetes Using the Time2Focus Mobile App for Diabetes Education: Pilot Evaluation. 
  • Generalizability of glucagon-like peptide-1 receptor agonist cardiovascular outcome trials enrollment criteria to the US type 2 diabetes population. 
  • Genetic Correlations Between Diabetes and Glaucoma: An Analysis of Continuous and Dichotomous Phenotypes. 
  • Genetic Predisposition to Coronary Artery Disease in Type 2 Diabetes Mellitus. 
  • Genetic Sharing with Cardiovascular Disease Risk Factors and Diabetes Reveals Novel Bone Mineral Density Loci. 
  • Genetic Variants in CPA6 and PRPF31 Are Associated With Variation in Response to Metformin in Individuals With Type 2 Diabetes. 
  • Genetic and pharmacological relationship between P-glycoprotein and increased cardiovascular risk associated with clarithromycin prescription: An epidemiological and genomic population-based cohort study in Scotland, UK. 
  • Genetic associations of type 2 diabetes with islet amyloid polypeptide processing and degrading pathways in asian populations. 
  • Genetic inactivation of ANGPTL4 improves glucose homeostasis and is associated with reduced risk of diabetes. 
  • Genetic insights into biological mechanisms governing human ovarian ageing. 
  • Genetic risk reclassification for type 2 diabetes by age below or above 50 years using 40 type 2 diabetes risk single nucleotide polymorphisms. 
  • Genetic variants primarily associated with type 2 diabetes are related to coronary artery disease risk. 
  • Genome-wide association study for circulating levels of PAI-1 provides novel insights into its regulation. 
  • Genome-wide association study identifies a novel locus contributing to type 2 diabetes susceptibility in Sikhs of Punjabi origin from India. 
  • Genome-wide association study identifies seven novel susceptibility loci for primary open-angle glaucoma. 
  • Genome-wide association study in a Chinese population identifies a susceptibility locus for type 2 diabetes at 7q32 near PAX4. 
  • Genome-wide association study in individuals of South Asian ancestry identifies six new type 2 diabetes susceptibility loci. 
  • Genome-wide trans-ancestry meta-analysis provides insight into the genetic architecture of type 2 diabetes susceptibility. 
  • Genomewide search for type 2 diabetes susceptibility genes in four American populations. 
  • Genotype prediction of adult type 2 diabetes from adolescence in a multiracial population. 
  • Genotypic effect of the -565C>T polymorphism in the ABCA1 gene promoter on ABCA1 expression and severity of atherosclerosis. 
  • Gestational retinal microvasculature and the risk of 5 year postpartum abnormal glucose metabolism. 
  • Getting biological about the genetics of diabetes. 
  • Global epigenomic analysis of primary human pancreatic islets provides insights into type 2 diabetes susceptibility loci. 
  • Glucagon receptor as a drug target: A witches' brew of eye of newt (peptides) and toe of frog (receptors). 
  • Glucagon-Like Peptide 1 Receptor Agonists and Heart Failure: The Need for Further Evidence Generation and Practice Guidelines Optimization. 
  • Glucagon-like peptide 1 (GLP-1). 
  • Glucokinase gene transfer to skeletal muscle of diabetic Zucker fatty rats improves insulin-sensitive glucose uptake. 
  • Glucokinase overexpression restores glucose utilization and storage in cultured hepatocytes from male Zucker diabetic fatty rats. 
  • Glucose and lipid effects of the ileal apical sodium-dependent bile acid transporter inhibitor GSK2330672: double-blind randomized trials with type 2 diabetes subjects taking metformin. 
  • Glucose metabolism gene variants modulate the risk of pancreatic cancer. 
  • Glucose transport and sensing in the maintenance of glucose homeostasis and metabolic harmony. 
  • Glycemia Reduction in Type 2 Diabetes - Microvascular and Cardiovascular Outcomes. 
  • Glycemic Control and Insulin Treatment Alter Fracture Risk in Older Men With Type 2 Diabetes Mellitus. 
  • Glycemic load, exercise, and monitoring blood glucose (GEM): A paradigm shift in the treatment of type 2 diabetes mellitus. 
  • Glycemic monitoring in diabetics with sickle cell plus beta-thalassemia hemoglobinopathy. 
  • Glycemic response to stress is altered in euglycemic Pima Indians. 
  • Glycerate from intestinal fructose metabolism induces islet cell damage and glucose intolerance. 
  • Glycogen synthase: a putative locus for diet-induced hyperglycemia. 
  • Going with the flow: adaptation of β-cell function to glucose fluxes after bariatric surgery. 
  • Granulicatella Adiacens as an Unusual Cause of Microbial Keratitis and Endophthalmitis: A Case Series and Literature Review. 
  • Group Coaching Among African-American Individuals with Prediabetes in a Faith-Based Setting. 
  • Group diabetes self-management education in a primary care setting: a quality improvement project. 
  • Guidelines for Cardiovascular Risk Reduction in Patients With Type 2 Diabetes: JACC Guideline Comparison. 
  • Gut hormone pharmacology of a novel GPR119 agonist (GSK1292263), metformin, and sitagliptin in type 2 diabetes mellitus: results from two randomized studies. 
  • Gut peptides in the treatment of diabetes mellitus. 
  • Gαi/o-coupled receptor signaling restricts pancreatic β-cell expansion. 
  • HNF-4alpha: from MODY to late-onset type 2 diabetes. 
  • Haptoglobin Genotype as a Prognostic Factor for Adverse Events in Coronary Artery Bypass Surgery in Diabetic Patients. 
  • Harmony Outcomes: A randomized, double-blind, placebo-controlled trial of the effect of albiglutide on major cardiovascular events in patients with type 2 diabetes mellitus-Rationale, design, and baseline characteristics. 
  • Health coaching and genetic risk testing in primary care: Randomized controlled trial. 
  • Health education via mobile text messaging for glycemic control in adults with type 2 diabetes: a systematic review and meta-analysis. 
  • Heart Failure End Points in Cardiovascular Outcome Trials of Sodium Glucose Cotransporter 2 Inhibitors in Patients With Type 2 Diabetes Mellitus: A Critical Evaluation of Clinical and Regulatory Issues. 
  • Heart Failure: An Underappreciated Complication of Diabetes. A Consensus Report of the American Diabetes Association. 
  • Heart failure event definitions in drug trials in patients with type 2 diabetes. 
  • Heart matters: Gender and racial differences cardiovascular disease risk factor control among veterans. 
  • Hemoglobin A1c and postpartum abnormal glucose tolerance among women with gestational diabetes mellitus. 
  • Hepatic complications of obesity. 
  • Hepatic insulin signaling is required for obesity-dependent expression of SREBP-1c mRNA but not for feeding-dependent expression. 
  • Hepatic steatosis and type 2 diabetes mellitus. 
  • Heterogeneity of Treatment Effects Among Patients With Type 2 Diabetes and Elevated Body Mass Index in a Study Comparing Group Medical Visits Focused on Weight Management and Medication Intensification. 
  • High-density lipoprotein maintains skeletal muscle function by modulating cellular respiration in mice. 
  • Higher burden of cardiometabolic and socioeconomic risk factors in women with type 2 diabetes: an analysis of the Glycemic Reduction Approaches in Diabetes (GRADE) baseline cohort. 
  • Higher dietary fructose is associated with impaired hepatic adenosine triphosphate homeostasis in obese individuals with type 2 diabetes. 
  • Hostility and fasting glucose in African American women. 
  • Hostility and minimal model of glucose kinetics in African American women. 
  • How should you assess glycemic control if the hemoglobin A1c is inaccurate or uninterpretable? 
  • Hypercholesterolemia and prostate cancer: a hospital-based case-control study. 
  • Hypertension in CB57BL/6J mouse model of non-insulin-dependent diabetes mellitus. 
  • Hypoglycemia Communication in Primary Care Visits for Patients with Diabetes. 
  • ISPAD Clinical Practice Consensus Guidelines 2014. Microvascular and macrovascular complications in children and adolescents. 
  • Identification and functional characterization of G6PC2 coding variants influencing glycemic traits define an effector transcript at the G6PC2-ABCB11 locus. 
  • Identification of genetic markers to 20 NIDDM candidate genes by radiation hybrid analysis. 
  • Identifying the causes of the changes in the prevalence patterns of diabetes in older U.S. adults: A new trend partitioning approach. 
  • IgG-lambda plasma cell myeloma with cytoplasmic azurophilic inclusion bodies. 
  • Images of illness: how causal claims and racial associations influence public preferences toward diabetes research spending. 
  • Impact of Gender on Satisfaction and Confidence in Cholesterol Control Among Veterans at Risk for Cardiovascular Disease. 
  • Impact of Genetic Testing and Family Health History Based Risk Counseling on Behavior Change and Cognitive Precursors for Type 2 Diabetes. 
  • Impact of Regulatory Guidance on Evaluating Cardiovascular Risk of New Glucose-Lowering Therapies to Treat Type 2 Diabetes Mellitus: Lessons Learned and Future Directions. 
  • Impact of School Nurse Ratios and Health Services on Selected Student Health and Education Outcomes: North Carolina, 2011-2016. 
  • Impact of a clinical pharmacist on provider prescribing patterns in a primary care clinic. 
  • Impact of baseline insulin regimen on glycemic response to a group medical clinic intervention. 
  • Impact of behavioral interventions in the management of adults with type 2 diabetes mellitus. 
  • Impact of common genetic determinants of Hemoglobin A1c on type 2 diabetes risk and diagnosis in ancestrally diverse populations: A transethnic genome-wide meta-analysis. 
  • Impact of delivery models on understanding genomic risk for type 2 diabetes. 
  • Impact of diabetes mellitus on clinical characteristics, management, and in-hospital outcomes in patients with acute myocardial infarction (from the NCDR). 
  • Impact of diabetes on the effects of sodium glucose co-transporter-2 inhibitors on kidney outcomes: collaborative meta-analysis of large placebo-controlled trials. 
  • Impact of glucose self-monitoring on non-insulin-treated patients with type II diabetes mellitus. Randomized controlled trial comparing blood and urine testing. 
  • Impact of glycemic control strategies on the progression of diabetic peripheral neuropathy in the Bypass Angioplasty Revascularization Investigation 2 Diabetes (BARI 2D) Cohort. 
  • Impact of laparoscopic adjustable gastric banding on type 2 diabetes. 
  • Impact of metformin use on the cardiovascular effects of dipeptidyl peptidase-4 inhibitors: An analysis of Medicare claims data from 2007 to 2015. 
  • Impact of migration and acculturation on prevalence of type 2 diabetes and related eye complications in Indians living in a newly urbanised society. 
  • Impact of race on pancreas transplant outcomes in the current era: It is not all Black and White. 
  • Impaired angiogenesis after hindlimb ischemia in type 2 diabetes mellitus: differential regulation of vascular endothelial growth factor receptor 1 and soluble vascular endothelial growth factor receptor 1. 
  • Impaired beta-cell sensitivity to glucose and maximal insulin secretory capacity in adolescents with type 2 diabetes. 
  • Impaired expression and functional activity of the beta 3- and beta 1-adrenergic receptors in adipose tissue of congenitally obese (C57BL/6J ob/ob) mice. 
  • Impaired second phase insulin response of diabetes-prone C57BL/6J mouse islets. 
  • Implementation and evaluation of the VA DPP clinical demonstration: protocol for a multi-site non-randomized hybrid effectiveness-implementation type III trial. 
  • Implementation findings from a hybrid III implementation-effectiveness trial of the Diabetes Prevention Program (DPP) in the Veterans Health Administration (VHA). 
  • Implementation of a Multidisciplinary Diabetes Self-Management Training Class in Acute Rehabilitation. 
  • Implementation of a prediabetes identification algorithm for overweight and obese Veterans. 
  • Implementation of an Intensive Telehealth Intervention for Rural Patients with Clinic-Refractory Diabetes. 
  • Implementing a low-carbohydrate, ketogenic diet to manage type 2 diabetes mellitus. 
  • Implications of the Hemoglobin Glycation Index on the Diagnosis of Prediabetes and Diabetes. 
  • Improved glycemic control enhances the incretin effect in patients with type 2 diabetes. 
  • Improved insulin sensitivity after gastric bypass correlates with decreased total body fat, but not with changes in free fatty acids. 
  • Improving health engagement and lifestyle management for breast cancer survivors with diabetes. 
  • In CV disease, GLP-1 RAs and SGLT2 inhibitors reduce CV mortality. 
  • In mice with type 2 diabetes, a vascular endothelial growth factor (VEGF)-activating transcription factor modulates VEGF signaling and induces therapeutic angiogenesis after hindlimb ischemia. 
  • In type 2 diabetes, the BT-001 smartphone app reduced HbA1c more than a control app at 90 d. 
  • In-Hospital Initiation of Sodium-Glucose Cotransporter-2 Inhibitors for Heart Failure With Reduced Ejection Fraction. 
  • Incidence and Progression of Chronic Kidney Disease in Black and White Individuals with Type 2 Diabetes. 
  • Incidence of atrial fibrillation in a population with impaired glucose tolerance: the contribution of glucose metabolism and other risk factors. A post hoc analysis of the Nateglinide and Valsartan in Impaired Glucose Tolerance Outcomes Research trial. 
  • Incidence of statin use in older adults with and without cardiovascular disease and diabetes mellitus, January 2008- March 2018. 
  • Increased Risk of Severe Hypoglycemic Events Before and After Cardiovascular Outcomes in TECOS Suggests an At-Risk Type 2 Diabetes Frail Patient Phenotype. 
  • Increasing Dietary Medium-Chain Fatty Acid Ratio Mitigates High-fat Diet-Induced Non-Alcoholic Steatohepatitis by Regulating Autophagy. 
  • Increasing fructose 2,6-bisphosphate overcomes hepatic insulin resistance of type 2 diabetes. 
  • Incremental cost-effectiveness of algorithm-driven genetic testing versus no testing for Maturity Onset Diabetes of the Young (MODY) in Singapore. 
  • Incretin mimetics as emerging treatments for type 2 diabetes. 
  • Individuals' Perspectives on Coping with Vision Loss from Diabetic Retinopathy. 
  • Induction of miR-132 and miR-212 Expression by Glucagon-Like Peptide 1 (GLP-1) in Rodent and Human Pancreatic β-Cells. 
  • Influence of obesity-related risk factors in the aetiology of glioma. 
  • Information-seeking and sharing behavior following genomic testing for diabetes risk. 
  • Inhibitory G proteins and their receptors: emerging therapeutic targets for obesity and diabetes. 
  • Initial injectable therapy in type 2 diabetes: Key considerations when choosing between glucagon-like peptide 1 receptor agonists and insulin. 
  • Insomnia symptoms as a cause of type 2 diabetes Incidence: a 20 year cohort study. 
  • Insulin action, type 2 diabetes, and branched-chain amino acids: A two-way street. 
  • Insulin treatment and clinical outcomes in patients with diabetes and heart failure with preserved ejection fraction. 
  • Integration of Personalized Health Planning and Shared Medical Appointments for Patients with Type 2 Diabetes Mellitus. 
  • Intensive glycemic control is not associated with fractures or falls in the ACCORD randomized trial. 
  • Intermediate Diabetes Outcomes in Patients Managed by Physicians, Nurse Practitioners, or Physician Assistants: A Cohort Study. 
  • Intermittent fasting vs daily calorie restriction for type 2 diabetes prevention: a review of human findings. 
  • International Variation in Outcomes Among People with Cardiovascular Disease or Cardiovascular Risk Factors and Impaired Glucose Tolerance: Insights from the NAVIGATOR Trial. 
  • International variation in characteristics and clinical outcomes of patients with type 2 diabetes and heart failure: Insights from TECOS. 
  • Internet delivered diabetes self-management education: a review. 
  • Intersession variability in single-breath diffusing capacity in diabetics without overt lung disease. 
  • Intravitreal aflibercept for diabetic macular edema. 
  • Is Roux-en-Y gastric bypass surgery the most effective treatment for type 2 diabetes mellitus in morbidly obese patients? 
  • Is depression associated with microvascular disease in patients with type 2 diabetes? 
  • Is diabetes mellitus-linked amino acid signature associated with β-blocker-induced impaired fasting glucose? 
  • Is nuclear magnetic resonance lipoprotein subclass related to diabetic retinopathy? The multi-ethnic study of atherosclerosis (MESA). 
  • Is overweight and class I obesity associated with increased health claims costs? 
  • Is silent myocardial infarction more common in women with type 2 diabetes than in men? 
  • Islet amyloid formation associated with hyperglycemia in transgenic mice with pancreatic beta cell expression of human islet amyloid polypeptide. 
  • Islet α cells and glucagon--critical regulators of energy homeostasis. 
  • Isocitrate-to-SENP1 signaling amplifies insulin secretion and rescues dysfunctional β cells. 
  • JCL Roundtable. Obesity, Diabetes, and Liver Disease in Relation to Cardiovascular Risk. 
  • Jump starting shared medical appointments for diabetes with weight management: Rationale and design of a randomized controlled trial. 
  • KCNJ11 variants and their effect on the association between serum potassium and diabetes risk in the Atherosclerosis Risk in Communities (ARIC) Study and Jackson Heart Study (JHS) cohorts. 
  • Kidney Outcomes Associated With SGLT2 Inhibitors Versus Other Glucose-Lowering Drugs in Real-world Clinical Practice: The Japan Chronic Kidney Disease Database. 
  • Kv2.1 Clustering Contributes to Insulin Exocytosis and Rescues Human β-Cell Dysfunction. 
  • LY3298176, a novel dual GIP and GLP-1 receptor agonist for the treatment of type 2 diabetes mellitus: From discovery to clinical proof of concept. 
  • LY3437943, a novel triple GIP, GLP-1, and glucagon receptor agonist in people with type 2 diabetes: a phase 1b, multicentre, double-blind, placebo-controlled, randomised, multiple-ascending dose trial. 
  • Lack of interaction of beta-cell-function-associated variants with hypertension on change in fasting glucose and diabetes risk: the Framingham Offspring Study. 
  • Language barrier and its relationship to diabetes and diabetic retinopathy. 
  • Laparoscopic nephron-sparing surgery in a Jehovah's Witness patient. 
  • Large-scale pharmacogenomic study of sulfonylureas and the QT, JT and QRS intervals: CHARGE Pharmacogenomics Working Group. 
  • Lifestyle factors and fetal and childhood origins of type 2 diabetes: a prospective study of Chinese and European adults. 
  • Lifetime cost-effectiveness simulation of once-weekly exenatide in type 2 diabetes: A cost-utility analysis based on the EXSCEL trial. 
  • Linagliptin Effects on Heart Failure and Related Outcomes in Individuals With Type 2 Diabetes Mellitus at High Cardiovascular and Renal Risk in CARMELINA. 
  • Lipid Effects of Icosapent Ethyl in Women with Diabetes Mellitus and Persistent High Triglycerides on Statin Treatment: ANCHOR Trial Subanalysis. 
  • Lipid kinase PIK3C3 maintains healthy brown and white adipose tissues to prevent metabolic diseases. 
  • Lipid-altering efficacy and safety profile of combination therapy with ezetimibe/statin vs. statin monotherapy in patients with and without diabetes: an analysis of pooled data from 27 clinical trials. 
  • Lipid-induced metabolic dysfunction in skeletal muscle. 
  • Liver dysfunction in paediatric obesity: a randomized, controlled trial of metformin. 
  • Long circulating genetically encoded intrinsically disordered zwitterionic polypeptides for drug delivery. 
  • Long-echo time MR spectroscopy for skeletal muscle acetylcarnitine detection. 
  • Long-term efficacy and safety of ezetimibe/simvastatin coadministered with extended-release niacin in hyperlipidaemic patients with diabetes or metabolic syndrome. 
  • Long-term outcomes of analogue insulin compared with NPH for patients with type 2 diabetes mellitus. 
  • Longer axial length is protective of diabetic retinopathy and macular edema. 
  • Longitudinal HbA1c trajectory modelling reveals the association of HbA1c and risk of hospitalization for heart failure for patients with type 2 diabetes mellitus. 
  • Longitudinal incidence and prevalence of adverse outcomes of diabetes mellitus in elderly patients. 
  • Longitudinal medical resources and costs among type 2 diabetes patients participating in the Trial Evaluating Cardiovascular Outcomes with Sitagliptin (TECOS). 
  • Longitudinal multi-omics of host-microbe dynamics in prediabetes. 
  • Losartan potassium (Cozaar). 
  • Low-Dose Levothyroxine Reduces Intrahepatic Lipid Content in Patients With Type 2 Diabetes Mellitus and NAFLD. 
  • Low-density lipoprotein cholesterol level and statin use among Medicare beneficiaries with diabetes mellitus. 
  • Low-density lipoprotein cholesterol treatment and outcomes in patients with type 2 diabetes and established cardiovascular disease: Insights from TECOS. 
  • Low-frequency and rare exome chip variants associate with fasting glucose and type 2 diabetes susceptibility. 
  • Lower Urinary Tract Symptoms in Older Children With and Without Diabetes Mellitus. 
  • Malakoplakia of the prostate on needle core biopsy: a case report and review of the literature. 
  • Management of Hyperglycemia in Type 2 Diabetes, 2018. A Consensus Report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD). 
  • Management of Hyperglycemia in Type 2 Diabetes, 2022. A Consensus Report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD). 
  • Management of Preexisting Diabetes in Pregnancy: A Review. 
  • Management of hyperglycaemia in type 2 diabetes, 2018. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD). 
  • Management of hyperglycaemia in type 2 diabetes, 2022. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD). 
  • Management of newly treated diabetes in Medicare beneficiaries with and without heart failure. 
  • Management of type 2 diabetes in Asian Indians: a review of the literature. 
  • Managing hyperglycemia and diabetes in patients receiving enteral feedings: A health system approach. 
  • Manganese superoxide dismutase expression in endothelial progenitor cells accelerates wound healing in diabetic mice. 
  • Mapping genes for NIDDM. Design of the Finland-United States Investigation of NIDDM Genetics (FUSION) Study. 
  • Maternal BMI and Glycemia Impact the Fetal Metabolome. 
  • Measurement Properties of Patient-Reported Outcome Measures for Diabetes: Systematic Review. 
  • Mechanisms controlling pancreatic islet cell function in insulin secretion. 
  • Mechanisms of disease:Molecular and metabolic mechanisms of insulin resistance and beta-cell failure in type 2 diabetes. 
  • Mechanisms of surgical control of type 2 diabetes: GLP-1 is the key factor-Maybe. 
  • Mediation considerations: serum potassium and the racial disparity in diabetes risk. 
  • Medical clinics versus usual care for patients with both diabetes and hypertension: a randomized trial. 
  • Medicare utilization, screening, and costs among participants in the Southeastern Diabetes Initiative: A population-based evaluation. 
  • Meeting report: targeting protein phosphatases-medicines for the new millenium. 
  • Meta-analysis of gene-environment interaction: joint estimation of SNP and SNP × environment regression coefficients. 
  • Meta-analysis of genome-wide association studies identifies eight new loci for type 2 diabetes in east Asians. 
  • Meta-analysis of genome-wide association studies in African Americans provides insights into the genetic architecture of type 2 diabetes. 
  • Metabolic Syndrome Among Antiretroviral Therapy-Naive Versus Experienced HIV-Infected Patients Without Preexisting Cardiometabolic Disorders in Western Kenya. 
  • Metabolic syndrome and risk of age-related cataract over time: an analysis of interval-censored data using a random-effects model. 
  • Metabolic syndrome components and age-related cataract: the Singapore Malay eye study. 
  • Metabolism: A is for adipokine. 
  • Metabolites and diabetes remission after weight loss. 
  • Metabolomic Profiling of the Effects of Dapagliflozin in Heart Failure With Reduced Ejection Fraction: DEFINE-HF. 
  • Metabolomic profile associated with insulin resistance and conversion to diabetes in the Insulin Resistance Atherosclerosis Study. 
  • Metabolomics applied to diabetes research: moving from information to knowledge. 
  • Metabolomics applied to the pancreatic islet. 
  • Metformin Is Associated with Higher Incidence of Acidosis, but Not Mortality, in Individuals with COVID-19 and Pre-existing Type 2 Diabetes. 
  • Metformin Use May Moderate the Effect of DPP-4 Inhibitors on Cardiovascular Outcomes. 
  • Metformin association with lower prostate cancer recurrence in type 2 diabetes: a systematic review and meta-analysis. 
  • Metformin exposure is associated with improved progression-free survival in diabetic patients after resection for early-stage non-small cell lung cancer. 
  • Metformin, Diabetes, and Survival among U.S. Veterans with Colorectal Cancer-Response. 
  • Metformin, Diabetes, and Survival among U.S. Veterans with Colorectal Cancer. 
  • Methodology and early findings of the Diabetes Management Project: a cohort study investigating the barriers to optimal diabetes care in diabetic patients with and without diabetic retinopathy. 
  • Microvascular and Cardiovascular Outcomes According to Renal Function in Patients Treated With Once-Weekly Exenatide: Insights From the EXSCEL Trial. 
  • Mindfulness-Based Stress Reduction in Advanced Nursing Practice: A Nonpharmacologic Approach to Health Promotion, Chronic Disease Management, and Symptom Control. 
  • Minimal difference between aerobic and progressive resistance exercise on metabolic profile and fitness in older adults with diabetes mellitus: a randomised trial. 
  • Modelling diabetic nephropathy in mice. 
  • Moderate consumption of white and fortified wine is associated with reduced odds of diabetic retinopathy. 
  • Modifiable disease risk, readiness to change, and psychosocial functioning improve with integrative medicine immersion model. 
  • Modification of postprandial hyperglycemia with insulin lispro improves glucose control in patients with type 2 diabetes. 
  • Molecular and Materials Engineering for Delivery of Peptide Drugs to Treat Type 2 Diabetes. 
  • Molecular cloning of a novel member of the GLUT family of transporters, SLC2a10 (GLUT10), localized on chromosome 20q13.1: a candidate gene for NIDDM susceptibility. 
  • Molecular strategies for the treatment of diabetes. 
  • Monocyte miRNAs Are Associated With Type 2 Diabetes. 
  • Morphological changes in human nuclear cataracts of late-onset diabetics. 
  • Mortality and Macrovascular Risk in Elderly With Hypertension and Diabetes: Effect of Intensive Drug Therapy. 
  • Mouse models of diabetic nephropathy. 
  • Mucormycosis. 
  • Multi-ancestry genetic study of type 2 diabetes highlights the power of diverse populations for discovery and translation. 
  • Multiethnic Genome-Wide Association Study of Diabetic Retinopathy Using Liability Threshold Modeling of Duration of Diabetes and Glycemic Control. 
  • Multiethnic polygenic risk scores improve risk prediction in diverse populations. 
  • Multilevel examination of diabetes in modernising China: what elements of urbanisation are most associated with diabetes? 
  • Multiple genetic variants explain measurable variance in type 2 diabetes-related traits in Pakistanis. 
  • Mutational analysis of the coding regions of the genes encoding protein kinase B-alpha and -beta, phosphoinositide-dependent protein kinase-1, phosphatase targeting to glycogen, protein phosphatase inhibitor-1, and glycogenin: lessons from a search for genetic variability of the insulin-stimulated glycogen synthesis pathway of skeletal muscle in NIDDM patients. 
  • NAFLD, NASH and liver cancer. 
  • Natriuretic peptides and primary prevention: the new world? 
  • Neck circumference and the development of cardiovascular disease risk factors in the Framingham Heart Study. 
  • Need for insulin therapy in type II diabetes mellitus. A randomized trial. 
  • New antihyperglycemic medications with cardiovascular protection for patients with diabetes: What do surgeons need to know? 
  • New combination treatments in the management of diabetes: focus on sitagliptin-metformin. 
  • New onset of type 2 diabetes after colorectal cancer diagnosis: Results from three prospective US cohort studies, systematic review, and meta-analysis. 
  • New strategies in pancreatic cancer: emerging epidemiologic and therapeutic concepts. 
  • New therapies for type 2 diabetes based on glucagon-like peptide 1. 
  • New ways in which GLP-1 can regulate glucose homeostasis. 
  • Newer Drugs to Reduce High Blood Pressure and Mitigate Hypertensive Target Organ Damage. 
  • Newer second-line glucose-lowering drugs versus thiazolidinediones on cirrhosis risk among older US adult patients with type 2 diabetes. 
  • Niclosamide-conjugated polypeptide nanoparticles inhibit Wnt signaling and colon cancer growth. 
  • Niclosamide: Beyond an antihelminthic drug. 
  • Nighttime blood pressure, nighttime glucose values, and target-organ damages in treated type 2 diabetes patients. 
  • Non-communicable disease syndemics: poverty, depression, and diabetes among low-income populations. 
  • Non-insulin-dependent diabetic microangiopathy in the inner ear. 
  • Non-invasive diagnosis of nonalcoholic fatty liver disease in patients with type 2 diabetes. 
  • Not all roads lead to Rome-a review of quality of life measurement in adults with diabetes. 
  • Novel Risk Factors for Type 2 Diabetes in African-Americans. 
  • Novel cancer therapies and their association with diabetes. 
  • Novel loci for adiponectin levels and their influence on type 2 diabetes and metabolic traits: a multi-ethnic meta-analysis of 45,891 individuals. 
  • Nurse practitioner management of type 2 diabetes. 
  • Nurse-led behavioral management of diabetes and hypertension in community practices: a randomized trial. 
  • Nutritional basis of type 2 diabetes remission. 
  • Nutritional concerns in American Indian and Alaska Native children: transitions and future directions. 
  • OB-Rb gene transfer to leptin-resistant islets reverses diabetogenic phenotype. 
  • Obesity and risk for hypertension and diabetes among Kenyan adults: Results from a national survey. 
  • Obesity in American-Indian children: prevalence, consequences, and prevention. 
  • Obesity, Diabetes, and Acute Coronary Syndrome: Differences Between Asians and Whites. 
  • Observational study of subclinical diabetic macular edema. 
  • Observational study of the development of diabetic macular edema following panretinal (scatter) photocoagulation given in 1 or 4 sittings. 
  • Occurrence of amino acid mutation (Ala98Val) of HNF1α in association with type II diabetes. 
  • Once-Weekly Exenatide and Cardiovascular Outcomes in Type 2 Diabetes. 
  • One small step for mice, one giant leap for GWAS? 
  • One-year comparison of a high-monounsaturated fat diet with a high-carbohydrate diet in type 2 diabetes. 
  • One-year sustained glycemic control and weight reduction in type 2 diabetes after addition of liraglutide to metformin followed by insulin detemir according to HbA1c target. 
  • Opportunities for improving use of evidence-based therapy in patients with type 2 diabetes and cardiovascular disease. 
  • Outcomes of Eyes Lost to Follow-up with Proliferative Diabetic Retinopathy That Received Panretinal Photocoagulation versus Intravitreal Anti-Vascular Endothelial Growth Factor. 
  • Overexpression of leptin receptors in pancreatic islets of Zucker diabetic fatty rats restores GLUT-2, glucokinase, and glucose-stimulated insulin secretion. 
  • Oxidative stress and nerve function after cardiopulmonary bypass in patients with diabetes. 
  • Oxygen-carrying proteins in meat and risk of diabetes mellitus. 
  • P-wave axis is associated with all-cause mortality in diabetes: The ACCORD trial. 
  • PUFA supplements and type 2 diabetes in the elderly. 
  • Pancreatic Safety of Sitagliptin in the TECOS Study. 
  • Paradoxical activation of transcription factor SREBP1c and de novo lipogenesis by hepatocyte-selective ATP-citrate lyase depletion in obese mice. 
  • Partial Meal Replacement Plan and Quality of the Diet at 1 Year: Action for Health in Diabetes (Look AHEAD) Trial. 
  • Participation of Racial and Ethnic Minorities in Technology-Based Interventions to Self-Manage Type 2 Diabetes: A Scoping Review. 
  • Pathogenesis and prevention of type 2 diabetes: parental determinants, breastfeeding, and early childhood nutrition. 
  • Pathogenesis of A⁻β⁺ ketosis-prone diabetes. 
  • Patient Phenotypes and SGLT-2 Inhibition in Type 2 Diabetes: Insights From the EMPA-REG OUTCOME Trial. 
  • Patient Preferences for Medications in Managing Type 2 Diabetes Mellitus: A Discrete Choice Experiment. 
  • Patient beliefs and behaviors about genomic risk for type 2 diabetes: implications for prevention. 
  • Patient-reported outcomes in patients with type 2 diabetes treated with liraglutide or glimepiride, both as add-on to metformin. 
  • Patients phenotypes and cardiovascular risk in type 2 diabetes: the Jackson Heart Study. 
  • Perceptions of Using Multiple Mobile Health Devices to Support Self-Management Among Adults With Type 2 Diabetes: A Qualitative Descriptive Study. 
  • Performance and improvement of the DiaRem score in diabetes remission prediction: a study with diverse procedure types. 
  • Periocular corticosteroids in diabetic papillopathy. 
  • Perioperative changes in prouroguanylin hormone response in severely obese subjects after bariatric surgery. 
  • Personality correlates of glycemic control in type 2 diabetes. 
  • Perturbation of fuel homeostasis caused by overexpression of the glucose-6-phosphatase catalytic subunit in liver of normal rats. 
  • Pharmacodynamic effect of cilostazol plus standard clopidogrel versus double-dose clopidogrel in patients with type 2 diabetes undergoing percutaneous coronary intervention. 
  • Pharmacokinetics of rifampicin. 
  • Pharmacologic Therapy for Heart Failure with Preserved Ejection Fraction. 
  • Pharmacologic approaches to the prevention of type 2 diabetes in high risk pediatric patients. 
  • Pharmacologic blockade of the natriuretic peptide clearance receptor promotes weight loss and enhances insulin sensitivity in type 2 diabetes. 
  • Physical activity and NIDDM in African-Americans. The Pitt County Study. 
  • Physical activity and non-insulin dependent diabetes mellitus. 
  • Physiology of weight loss surgery. 
  • Placental hormones and the control of fetal growth. 
  • Plasma acylcarnitine profiling indicates increased fatty acid oxidation relative to tricarboxylic acid cycle capacity in young, healthy low birth weight men. 
  • Plasma levels of DPP4 activity and sDPP4 are dissociated from inflammation in mice and humans. 
  • Plasma levels of beta-endorphin and adrenocorticotropic hormone in IDDM and NIDDM. 
  • Plasma metabolites associated with functional and clinical outcomes in heart failure with reduced ejection fraction with and without type 2 diabetes. 
  • Plasminogen activator inhibitor-1 (PAI-1) activity and retinal vascular calibre in type 2 diabetes. 
  • Poly-ADP-ribose-polymerase inhibition ameliorates hind limb ischemia reperfusion injury in a murine model of type 2 diabetes. 
  • Polymorphisms identified through genome-wide association studies and their associations with type 2 diabetes in Chinese, Malays, and Asian-Indians in Singapore. 
  • Polymorphisms of the HDL receptor gene associated with HDL cholesterol levels in diabetic kindred from three populations. 
  • Polymorphisms of the scavenger receptor class B member 1 are associated with insulin resistance with evidence of gene by sex interaction. 
  • Polyvascular disease and increased risk of cardiovascular events in patients with type 2 diabetes: Insights from the EXSCEL trial. 
  • Polyvascular disease, type 2 diabetes, and long-term vascular risk: a secondary analysis of the IMPROVE-IT trial. 
  • Poor metabolic and blood pressure control in patients with diabetic retinopathy attending a tertiary ophthalmic hospital in Australia. 
  • Population-Level Implications of Sodium-Glucose Cotransporter-2 Inhibitors for Heart Failure With Preserved Ejection Fraction in the US. 
  • Population-based cohort studies of type 2 diabetes and stomach cancer risk in Chinese men and women. 
  • Positive Impact of Continuous-Flow Left Ventricular Assist Device Implantation on Glycemic Control in Patients with Type 2 Diabetes Mellitus and Advanced Chronic Systolic Heart Failure. 
  • Postoperative hyperglycemia after 4- vs 8-10-mg dexamethasone for postoperative nausea and vomiting prophylaxis in patients with type II diabetes mellitus: a retrospective database analysis. 
  • Postpartum diabetes screening in women with a history of gestational diabetes. 
  • Postprandial metabolite profiles reveal differential nutrient handling after bariatric surgery compared with matched caloric restriction. 
  • Potassium intake and risk of incident type 2 diabetes mellitus: the Coronary Artery Risk Development in Young Adults (CARDIA) Study. 
  • Potential sensitivity of bias analysis results to incorrect assumptions of nondifferential or differential binary exposure misclassification. 
  • Practical Telemedicine for Veterans with Persistently Poor Diabetes Control: A Randomized Pilot Trial. 
  • Practical telehealth to improve control and engagement for patients with clinic-refractory diabetes mellitus (PRACTICE-DM): Protocol and baseline data for a randomized trial. 
  • Practice-linked online personal health records for type 2 diabetes mellitus: a randomized controlled trial. 
  • Prader Willi Syndrome: Genetics, Metabolomics, Hormonal Function, and New Approaches to Therapy. 
  • Pre-existing, Concurrent/Early-Onset, and Late-Onset Diabetes in Chronic Pancreatitis: Do Outcomes Differ? 
  • Preclinical developments in type 2 diabetes. 
  • Predicting major adverse limb events in individuals with type 2 diabetes: Insights from the EXSCEL trial. 
  • Prediction and validation of exenatide risk marker effects on progression of renal disease: Insights from EXSCEL. 
  • Predictors of Warfarin Time in Therapeutic Range after Continuous-Flow Left Ventricular Assist Device. 
  • Predictors of long-term weight loss in adults with modest initial weight loss, by sex and race. 
  • Predictors of weight regain in patients who underwent Roux-en-Y gastric bypass surgery. 
  • Pregnancy, pregnancy loss and the risk of diabetes in Chinese women: findings from the China Kadoorie Biobank. 
  • Preoperative carbohydrate loading in surgical patients with type 2 diabetes: Are concerns supported by data? 
  • Prevalence and Associations of Metabolic Syndrome in an Urban High Diabetes Risk Population in a Low/Middle-Income Country. 
  • Prevalence and Prognosis of Unrecognized Myocardial Infarction in Asymptomatic Patients With Diabetes: A Two-Center Study With Up to 5 Years of Follow-up. 
  • Prevalence and natural history of histologically proven chronic liver disease in a longitudinal cohort of patients with type 1 diabetes. 
  • Prevalence and risk factors of diabetic retinopathy in migrant Indians in an urbanized society in Asia: the Singapore Indian eye study. 
  • Prevalence of Diabetic Retinopathy and Blindness in Indonesian Adults With Type 2 Diabetes. 
  • Prevalence of and factors associated with sarcopenia among multi-ethnic ambulatory older Asians with type 2 diabetes mellitus in a primary care setting. 
  • Prevalence of asymptomatic bacteriuria in subjects with NIDDM in San Luis Valley of Colorado. 
  • Prevalence of depression and associated risk factors among persons with type-2 diabetes mellitus without a prior psychiatric history: a cross-sectional study in clinical settings in urban Nepal. 
  • Prevalence of diabetes and impaired fasting glucose in Poland--the NATPOL 2011 Study. 
  • Prevalence of diabetic peripheral neuropathy and relation to glycemic control therapies at baseline in the BARI 2D cohort. 
  • Prevalence of microvascular and macrovascular disease in the Glycemia Reduction Approaches in Diabetes - A Comparative Effectiveness (GRADE) Study cohort. 
  • Prevalence of obesity in American Indians and Alaska Natives. 
  • Prevalence of type 2 diabetes in patients with obstructive sleep apnea in a multi-ethnic sample. 
  • Prevalences of type 2 diabetes, the insulin resistance syndrome, and coronary heart disease in an elderly, biethnic population. 
  • Prevalent and Incident Heart Failure in Cardiovascular Outcome Trials of Patients With Type 2 Diabetes. 
  • Preventing Atrial Fibrillation With Treatments for Diabetes Mellitus. 
  • Preventing Heart Failure in Diabetes: Glycemic Targets or Class Effect? 
  • Primary Prevention of Heart Failure in Patients With Type 2 Diabetes Mellitus. 
  • Process- and Outcome-Based Financial Incentives to Improve Self-Management and Glycemic Control in People with Type 2 Diabetes in Singapore: A Randomized Controlled Trial. 
  • Prospective association between fasting NEFA and type 2 diabetes: impact of post-load glucose. 
  • Protectin DX alleviates insulin resistance by activating a myokine-liver glucoregulatory axis. 
  • Psychometric evaluation of the Persian version of the Type 2 Diabetes and Health Promotion Scale (T2DHPS): a diabetes-specific measure of lifestyle. 
  • Psychosocial support for people with diabetes: past, present and future. 
  • Psyllium fiber improves glycemic control proportional to loss of glycemic control: a meta-analysis of data in euglycemic subjects, patients at risk of type 2 diabetes mellitus, and patients being treated for type 2 diabetes mellitus. 
  • Public trust in genomic risk assessment for type 2 diabetes mellitus. 
  • Purulent Inflatable Penile Prostheses Can Be Safely Immediately Salvaged in Insulin-Dependent Diabetics. 
  • Quantitative trait locus mapping of human blood pressure to a genetic region at or near the lipoprotein lipase gene locus on chromosome 8p22. 
  • ROS signaling, oxidative stress and Nrf2 in pancreatic beta-cell function. 
  • Racial Differences in the Effectiveness of a Multifactorial Telehealth Intervention to Slow Diabetic Kidney Disease. 
  • Racial and Ethnic Approaches to Community Health (REACH) Detroit Partnership: Improving Diabetes-related Outcomes among African American and Latino Adults 
  • Racial differences in patient perception of interactions with providers are associated with health outcomes in type II diabetes. 
  • Racial differences in urinary F2-isoprostane levels and the cross-sectional association with BMI. 
  • Racial disparities in diabetes a century ago: evidence from the pension files of US Civil War veterans. 
  • Racial/Ethnic Differences in Glycemic Control in Older Adults with Type 2 Diabetes: United States 2003-2014. 
  • Racial/ethnic and educational-level differences in diabetes care experiences in primary care. 
  • Randomized clinical trial of quick-release bromocriptine among patients with type 2 diabetes on overall safety and cardiovascular outcomes. 
  • Randomized nutrition education intervention to improve carbohydrate counting in adolescents with type 1 diabetes study: is more intensive education needed? 
  • Rapid deterioration of insulin secretion in obese adolescents preceding the onset of type 2 diabetes. 
  • Rationale and Design for a GRADE Substudy of Continuous Glucose Monitoring. 
  • Rationale and Methodology for a Community-Based Study of Diabetic Retinopathy in an Indonesian Population with Type 2 Diabetes Mellitus: The Jogjakarta Eye Diabetic Study in the Community. 
  • Rationale and design of the EXenatide Study of Cardiovascular Event Lowering (EXSCEL) trial. 
  • Rationale and design of the Vitamin D and Type 2 Diabetes (D2d) study: a diabetes prevention trial. 
  • Rationale, design, and baseline characteristics of the CArdiovascular safety and Renal Microvascular outcomE study with LINAgliptin (CARMELINA®): a randomized, double-blind, placebo-controlled clinical trial in patients with type 2 diabetes and high cardio-renal risk. 
  • Rationale, design, and organization of a randomized, controlled Trial Evaluating Cardiovascular Outcomes with Sitagliptin (TECOS) in patients with type 2 diabetes and established cardiovascular disease. 
  • Re-adjudication of the Trial Evaluating Cardiovascular Outcomes with Sitagliptin (TECOS) with study-level meta-analysis of hospitalization for heart failure from cardiovascular outcomes trials with dipeptidyl peptidase-4 (DPP-4) inhibitors. 
  • Re: Effect of a ketogenic diet versus Mediterranean diet on glycated hemoglobin in individuals with prediabetes and type 2 diabetes mellitus: the interventional Keto-Med randomized crossover trial. 
  • Recognition and assessment of shift work disorder. 
  • Recombinant glucagon-like peptide-1 (7-36 amide) lowers fasting serum glucose in a broad spectrum of patients with type 2 diabetes. 
  • Recruitment and enrollment of participants in an online diabetes self-management intervention in a virtual environment. 
  • Red cell life span heterogeneity in hematologically normal people is sufficient to alter HbA1c. 
  • Reduced postprandial cholecystokinin (CCK) secretion in patients with noninsulin-dependent diabetes mellitus: evidence for a role for CCK in regulating postprandial hyperglycemia. 
  • Reduction of Cardiovascular Risk and Improved Estimated Glomerular Filtration Rate by SGLT2 Inhibitors, Including Dapagliflozin, Is Consistent Across the Class: An Analysis of the Placebo Arm of EXSCEL. 
  • Refining the accuracy of validated target identification through coding variant fine-mapping in type 2 diabetes. 
  • Regional Variation in Comorbid Prediabetes and Diabetes and Associated Factors among Hypertensive Individuals in Rural Bangladesh, Pakistan, and Sri Lanka. 
  • Regional fat distribution and metabolism in a new mouse model (C57BL/6J) of non-insulin-dependent diabetes mellitus. 
  • Regional, age and sex differences in baseline characteristics of patients enrolled in the Trial Evaluating Cardiovascular Outcomes with Sitagliptin (TECOS). 
  • Regulation of Glucose Production in the Pathogenesis of Type 2 Diabetes. 
  • Regulation of cerebral glucose metabolism. 
  • Regulation of skeletal muscle oxidative capacity and insulin signaling by the mitochondrial rhomboid protease PARL. 
  • Rejuvenation of Neutrophil Functions in Association With Reduced Diabetes Risk Following Ten Weeks of Low-Volume High Intensity Interval Walking in Older Adults With Prediabetes - A Pilot Study. 
  • Relation between BMI and diabetes mellitus and its complications among US older adults. 
  • Relation of severe coronary artery narrowing to insulin or thiazolidinedione use in patients with type 2 diabetes mellitus (from the Bypass Angioplasty Revascularization Investigation 2 Diabetes Study). 
  • Relations between deletion polymorphism of the angiotensin-converting enzyme gene and insulin resistance, glucose intolerance, hyperinsulinemia, and dyslipidemia. 
  • Relationship between diabetic retinopathy, diabetic macular oedema and erectile dysfunction in type 2 diabetics. 
  • Relationship of hemoglobin A1c with the presence and severity of retinopathy upon initial screening of type II diabetes mellitus. 
  • Relationships between metabolic syndrome and other baseline factors and the efficacy of ezetimibe/simvastatin and atorvastatin in patients with type 2 diabetes and hypercholesterolemia. 
  • Relationships of religion and spirituality to glycemic control in Black women with type 2 diabetes. 
  • Relaxation training for NIDDM. Predicting who may benefit. 
  • Religious Practices and Self-Care in Iranian Patients with Type 2 Diabetes. 
  • Remission of type 2 diabetes after Roux-en-Y gastric bypass is associated with greater weight loss. 
  • Renal Disease Risk Factors Among Risk Groups Comprised of African American Women With Type 2 Diabetes: A Secondary Analysis. 
  • Renal pathology patterns in type II diabetes mellitus: relationship with retinopathy. The Collaborative Study Group. 
  • Replication of genome-wide association signals of type 2 diabetes in Han Chinese in a prospective cohort. 
  • Reply: To PMID 22653543. 
  • Reporting of Sex Effects by Systematic Reviews on Interventions for Depression, Diabetes, and Chronic Pain. 
  • Repositioning metformin for cancer prevention and treatment. 
  • Reproducibility of spectral-domain optical coherence tomography retinal thickness measurements and conversion to equivalent time-domain metrics in diabetic macular edema. 
  • Residential Racial Isolation and Spatial Patterning of Type 2 Diabetes Mellitus in Durham, North Carolina. 
  • Resolving disease management problems in European-American and Latino couples with type 2 diabetes: the effects of ethnicity and patient gender. 
  • Response to comment on Tay et al. A very low-carbohydrate, low-saturated fat diet for type 2 diabetes management: a randomized trial. Diabetes Care 2014;37:2909-2918. 
  • Results From a Trial of an Online Diabetes Prevention Program Intervention. 
  • Results of Expert Meetings: Obesity and Cardiovascular Disease. Obesity as a risk factor in coronary artery disease. 
  • Results of a reevaluation of cardiovascular outcomes in the RECORD trial. 
  • Retinal Vessel Geometry and the Incidence and Progression of Diabetic Retinopathy. 
  • Retinal Vessel Tortuosity and Its Relation to Traditional and Novel Vascular Risk Markers in Persons with Diabetes. 
  • Retinal arteriolar caliber and urine albumin excretion: the Multi-Ethnic Study of Atherosclerosis. 
  • Retinal ganglion cell neuronal damage in diabetes and diabetic retinopathy. 
  • Retinal microvascular abnormalities and incident stroke: the Atherosclerosis Risk in Communities Study. 
  • Retinal thickness on Stratus optical coherence tomography in people with diabetes and minimal or no diabetic retinopathy. 
  • Retinal vascular caliber in persons with type 2 diabetes: the Wisconsin Epidemiological Study of Diabetic Retinopathy: XX. 
  • Retinal vascular caliber, diabetes, and retinopathy. 
  • Retinal vascular calibre as a predictor of incidence and progression of diabetic retinopathy. 
  • Retinal vessel caliber and microvascular and macrovascular disease in type 2 diabetes: XXI: the Wisconsin Epidemiologic Study of Diabetic Retinopathy. 
  • Reverse Cardiac Remodeling Following Initiation of Sacubitril/Valsartan in Patients With Heart Failure With and Without Diabetes. 
  • Review of selected Chinese herbal medicines in the treatment of type 2 diabetes. 
  • Revisiting NPH Insulin for Type 2 Diabetes: Is a Step Back the Path Forward? 
  • Right coronary wall CMR in the older asymptomatic advance cohort: positive remodeling and associations with type 2 diabetes and coronary calcium. 
  • Risk factors for diabetic retinopathy in a rural Chinese population with type 2 diabetes: the Handan Eye Study. 
  • Risk factors for hepatocellular carcinoma: synergism of alcohol with viral hepatitis and diabetes mellitus. 
  • Risk of stroke and cardiovascular events after ischemic stroke or transient ischemic attack in patients with type 2 diabetes or metabolic syndrome: secondary analysis of the Stroke Prevention by Aggressive Reduction in Cholesterol Levels (SPARCL) trial. 
  • Risk of type 2 diabetes and cumulative excess weight exposure in the Framingham Offspring Study. 
  • Risking health to avoid injections: preferences of Canadians with type 2 diabetes. 
  • Role of Mitochondrial Oxidative Stress in Glucose Tolerance, Insulin Resistance, and Cardiac Diastolic Dysfunction. 
  • Role of diabetes type in perioperative outcomes after hip and knee arthroplasty in the United States. 
  • Role of diuretics, β blockers, and statins in increasing the risk of diabetes in patients with impaired glucose tolerance: reanalysis of data from the NAVIGATOR study. 
  • Role of stress in the etiology and treatment of diabetes mellitus. 
  • Roles for SGLT2 Inhibitors in Cardiorenal Disease. 
  • Roux-en-Y gastric bypass decreases serum inflammatory markers and cardiovascular risk factors in obese diabetics. 
  • SGLT-2 Inhibitors for Patients with Heart Failure: What Have We Learned Recently? 
  • SGLT-2 inhibitors in patients with heart failure: a comprehensive meta-analysis of five randomised controlled trials. 
  • SLC2A10 genetic polymorphism predicts development of peripheral arterial disease in patients with type 2 diabetes. SLC2A10 and PAD in type 2 diabetes. 
  • Safety and tolerability of high-dose daily vitamin D3 supplementation in the vitamin D and type 2 diabetes (D2d) study-a randomized trial in persons with prediabetes. 
  • Screening adults for pre-diabetes and diabetes may be cost-saving. 
  • Screening for metabolic and reproductive complications in obese children and adolescents. 
  • Secondary Prevention of Cardiovascular Disease in Patients With Type 2 Diabetes Mellitus: International Insights From the TECOS Trial (Trial Evaluating Cardiovascular Outcomes With Sitagliptin). 
  • Self-management practices of Chinese Americans with type 2 diabetes. 
  • Self-monitoring diabetes with multiple mobile health devices. 
  • Self-monitoring of blood glucose in type 2 diabetes: systematic review. 
  • Sequence data and association statistics from 12,940 type 2 diabetes cases and controls. 
  • Sequential Multiple Assignment Randomized Trial (SMART) to identify optimal sequences of telemedicine interventions for improving initiation of insulin therapy: A simulation study. 
  • Sequential intensification of metformin treatment in type 2 diabetes with liraglutide followed by randomized addition of basal insulin prompted by A1C targets. 
  • Serial assessment of thrombogenicity and hemodynamics in patients with type II diabetes in a clinical research unit: Evidence for circadian variations in clot formation. 
  • Serum and dietary potassium and risk of incident type 2 diabetes mellitus: The Atherosclerosis Risk in Communities (ARIC) study. 
  • Serum apolipoproteins are associated with systemic and retinal microvascular function in people with diabetes. 
  • Serum calcium and its complex association with incident type 2 diabetes. 
  • Serum potassium and the racial disparity in diabetes risk: the Atherosclerosis Risk in Communities (ARIC) Study. 
  • Serum potassium is a predictor of incident diabetes in African Americans with normal aldosterone: the Jackson Heart Study. 
  • Setting the Stage for a Multimarker-Based Heart Failure Prevention Trial? 
  • Seven-year trajectories of body weight, quality of life and comorbidities following Roux-en-Y gastric bypass and sleeve gastrectomy. 
  • Sex Differences in Characteristics, Outcomes, and Treatment Response With Dapagliflozin Across the Range of Ejection Fraction in Patients With Heart Failure: Insights From DAPA-HF and DELIVER. 
  • Sex differences in cardiovascular risk factors before and after the development of type 2 diabetes and risk for incident cardiovascular disease. 
  • Sex differences in management and outcomes of patients with type 2 diabetes and cardiovascular disease: A report from TECOS. 
  • Sex differences in the association of psychosocial resources with prevalent type 2 diabetes among African Americans: The Jackson Heart Study. 
  • Sex differences in the complications, care and clinical outcomes of patients with type 2 diabetes in the Exenatide Study of Cardiovascular Event Lowering (EXSCEL). 
  • Sex differences in the relation of depressive symptoms, hostility, and anger expression to indices of glucose metabolism in nondiabetic adults. 
  • Short-term trajectories of use of a caloric-monitoring mobile phone app among patients with type 2 diabetes mellitus in a primary care setting. 
  • Simplifying therapy to assure glycemic control and engagement (STAGE) in poorly-controlled diabetes: A pilot study. 
  • Simultaneous Risk Factor Control Using Telehealth to slOw Progression of Diabetic Kidney Disease (STOP-DKD) study: Protocol and baseline characteristics of a randomized controlled trial. 
  • Simultaneous control of intermediate diabetes outcomes among Veterans Affairs primary care patients. 
  • Single Anastomosis Duodenal Switch: 1-Year Outcomes. 
  • Single-centre, triple-blinded, randomised, 1-year, parallel-group, superiority study to compare the effects of Roux-en-Y gastric bypass and sleeve gastrectomy on remission of type 2 diabetes and β-cell function in subjects with morbid obesity: a protocol for the Obesity surgery in Tønsberg (Oseberg) study. 
  • Sitagliptin and risk of fractures in type 2 diabetes: Results from the TECOS trial. 
  • Sitagliptin does not reduce the risk of cardiovascular death or hospitalization for heart failure following myocardial infarction in patients with diabetes: observations from TECOS. 
  • Skeletal muscle mitochondrial inertia is associated with carnitine acetyltransferase activity and physical function in humans. 
  • Sleep Disturbance, Diabetes, and Cardiovascular Disease in Postmenopausal Veteran Women. 
  • Slow and Steady Wins the Race: 25 Years Developing the GLP-1 Receptor as an Effective Target for Weight Loss. 
  • Social Support for Diabetes Self-Management via eHealth Interventions. 
  • Social interaction in type 2 diabetes computer-mediated environments: How inherent features of the channels influence peer-to-peer interaction. 
  • Sociocultural and socioeconomic influences on type 2 diabetes risk in overweight/obese African-American and Latino-American children and adolescents. 
  • Socioeconomic status and ethnic variation associated with type 2 diabetes mellitus in patients with uncontrolled hypertension in Singapore. 
  • Sodium Glucose Cotransporter-2 Inhibition for Acute Myocardial Infarction: JACC Review Topic of the Week. 
  • Sodium-Glucose Cotransporter 2 Inhibitors and Cardiac Remodeling. 
  • Sodium-Glucose Cotransporter-2 Inhibitors: Impact on Atherosclerosis and Atherosclerotic Cardiovascular Disease Events. 
  • Sodium-glucose co-transporter 2 inhibitors as an early, first-line therapy in patients with heart failure and reduced ejection fraction. 
  • Sodium-glucose co-transporter-2 inhibitor use and risk of lower-extremity amputation: Evolving questions, evolving answers. 
  • Sotagliflozin in Patients with Diabetes and Chronic Kidney Disease. 
  • Sotagliflozin in Patients with Diabetes and Recent Worsening Heart Failure. 
  • Special Considerations in the Management of Diabetes in Women. 
  • Stress and autonomic nervous system in type II diabetes. A hypothesis. 
  • Stress and diabetes mellitus. 
  • Stress management improves long-term glycemic control in type 2 diabetes. 
  • Subacute vision loss in a young, obese female. 
  • Substance use and mental diagnoses among adults with and without type 2 diabetes: Results from electronic health records data. 
  • Sugar pills for pancreatic cancer: the benefits of becoming (insulin) sensitive. 
  • Sulfonylurea Prescribing Patterns After the Introduction of DPP-4 Inhibitors and GLP-1 Receptor Agonists. 
  • Suppressive Effects of Insulin on Tumor Necrosis Factor-Dependent Early Osteoarthritic Changes Associated With Obesity and Type 2 Diabetes Mellitus. 
  • Surgical Treatment of Diabetes: Making a Case for a Pragmatic Approach. 
  • Survey analysis of patient experience using a practice-linked PHR for type 2 diabetes mellitus. 
  • Sustained release of a GLP-1 and FGF21 dual agonist from an injectable depot protects mice from obesity and hyperglycemia. 
  • Syndemic effects in complex humanitarian emergencies: A framework for understanding political violence and improving multi-morbidity health outcomes. 
  • Syndrome X and diabetes: what is the mystery? 
  • Systemic management of diabetic retinopathy. 
  • Systolic Blood Pressure Control Among Individuals With Type 2 Diabetes: A Comparative Effectiveness Analysis of Three Interventions. 
  • TCF1 links GIPR signaling to the control of beta cell function and survival. 
  • TRENDS IN THE CARE AND OUTCOMES OF MEDICARE BENEFICIARIES WITH TYPE 2 DIABETES, 2002-2011. 
  • TRIal to slow the Progression Of Diabetes (TRIPOD): study protocol for a randomized controlled trial using wireless technology and incentives. 
  • TXNIP links redox circuitry to glucose control. 
  • Tailored Case Management for Diabetes and Hypertension (TEACH-DM) in a community population: study design and baseline sample characteristics. 
  • Taking aim at islet hormones with GLP-1: is insulin or glucagon the better target? 
  • Targeted metabolomics finds its mark in diabetes research. 
  • Targeting beta-cell mass in type 2 diabetes: promise and limitations of new drugs based on incretins. 
  • Targeting the GIPR for obesity: To agonize or antagonize? Potential mechanisms. 
  • Targeting the Incretin/Glucagon System With Triagonists to Treat Diabetes. 
  • Telehealth for the Longitudinal Management of Chronic Conditions: Systematic Review. 
  • Tempol therapy attenuates medial smooth muscle cell apoptosis and neointima formation after balloon catheter injury in carotid artery of diabetic rats. 
  • Ten Emerging Trends in the Epidemiology of Diabetic Retinopathy. 
  • Testing a very low-carbohydrate adaption of the Diabetes Prevention Program among adults with prediabetes: study protocol for the Lifestyle Education about prediabetes (LEAP) trial. 
  • Tetrahydroindenoindole inhibits the progression of diabetes in mice. 
  • The "D" word. 
  • The 1p13.3 LDL (C)-associated locus shows large effect sizes in young populations. 
  • The 24-hour average concentration of cortisol is elevated in obese African-American youth with type 2 diabetes. 
  • The Cholesterol, Hypertension, And Glucose Education (CHANGE) study: results from a randomized controlled trial in African Americans with diabetes. 
  • The Cholesterol, Hypertension, and Glucose Education (CHANGE) study for African Americans with diabetes: study design and methodology. 
  • The Coronavirus Disease 2019 Pandemic is Associated with a Substantial Rise in Frequency and Severity of Presentation of Youth-Onset Type 2 Diabetes. 
  • The Dietary Approaches to Stop Hypertension (DASH) eating pattern in special populations. 
  • The Finland-United States investigation of non-insulin-dependent diabetes mellitus genetics (FUSION) study. I. An autosomal genome scan for genes that predispose to type 2 diabetes. 
  • The Finland-United States investigation of non-insulin-dependent diabetes mellitus genetics (FUSION) study. II. An autosomal genome scan for diabetes-related quantitative-trait loci. 
  • The MODY1 gene HNF-4alpha regulates selected genes involved in insulin secretion. 
  • The Neutrophil-to-Lymphocyte Ratio Determines Clinical Efficacy of Corticosteroid Therapy in Patients with COVID-19. 
  • The Pre-Diabetes Interventions and Continued Tracking to Ease-out Diabetes (Pre-DICTED) program: study protocol for a randomized controlled trial. 
  • The Relationship of Quantitative Retinal Capillary Network to Kidney Function in Type 2 Diabetes. 
  • The Relationship of Retinal Vessel Geometric Characteristics to the Incidence and Progression of Diabetic Retinopathy. 
  • The Role of the Adipokine Leptin in Immune Cell Function in Health and Disease. 
  • The SGLT2 inhibitor empagliflozin in patients hospitalized for acute heart failure: a multinational randomized trial. 
  • The TOMM40 poly-T rs10524523 variant is associated with cognitive performance among non-demented elderly with type 2 diabetes. 
  • The W64R variant of the beta3-adrenergic receptor is not associated with type II diabetes or obesity in a large Finnish sample. 
  • The association of impaired lung function and nonalcoholic fatty liver disease: a systematic review. 
  • The balance of benefit and safety of rosiglitazone: important lessons for our system of drug development and postmarketing assessment. 
  • The causal effects of health conditions and risk factors on social and socioeconomic outcomes: Mendelian randomization in UK Biobank. 
  • The changing demography of diabetes mellitus in Singapore. 
  • The contribution of enteroinsular hormones to the pathogenesis of type 2 diabetes mellitus. 
  • The cross-sectional association of cognition with diabetic peripheral and autonomic neuropathy-The GRADE study. 
  • The deadly sins and diabetes. 
  • The development, implementation, and process evaluation of the REACH Detroit Partnership's Diabetes Lifestyle Intervention. 
  • The dipeptidyl peptidase-4 inhibitors in type 2 diabetes mellitus: cardiovascular safety. 
  • The eMERGE Network: a consortium of biorepositories linked to electronic medical records data for conducting genomic studies. 
  • The economic burden of physical inactivity: a global analysis of major non-communicable diseases. 
  • The effect of anti-emetic doses of dexamethasone on postoperative blood glucose levels in non-diabetic and diabetic patients: a prospective randomised controlled study. 
  • The effect of chronic twice daily exenatide treatment on β-cell function in new onset type 2 diabetes. 
  • The effect of indapamide versus hydrochlorothiazide on ventricular and arterial function in patients with hypertension and diabetes: results of a randomized trial. 
  • The effect of vitamin D supplementation on cardiovascular risk in patients with prediabetes: A secondary analysis of the D2d study. 
  • The effectiveness of two community-based weight loss strategies among obese, low-income US Latinos. 
  • The effects of metformin on body mass index and glucose tolerance in obese adolescents with fasting hyperinsulinemia and a family history of type 2 diabetes. 
  • The effects of optimal perioperative glucose control on morbidly obese patients undergoing bariatric surgery. 
  • The emerging role of novel antihyperglycemic agents in the treatment of heart failure and diabetes: A focus on cardiorenal outcomes. 
  • The enteroinsular axis revisited. A novel role for an incretin. 
  • The family and disease management in Hispanic and European-American patients with type 2 diabetes. 
  • The family and type 2 diabetes: a framework for intervention. 
  • The genetic architecture of type 2 diabetes. 
  • The genetic regulatory signature of type 2 diabetes in human skeletal muscle. 
  • The girth of a nation--a call to arms...and legs. 
  • The how and why of stress, diabetes, and the brain. 
  • The impact of a produce prescription programme on healthy food purchasing and diabetes-related health outcomes. 
  • The impact of diabetic retinopathy and diabetic macular edema on health-related quality of life in type 1 and type 2 diabetes. 
  • The impact of hyperglycemia and obesity on hospitalization costs and clinical outcome in general surgery patients. 
  • The impact of race on metabolic disease risk factors in women with and without posttraumatic stress disorder. 
  • The incretin effect in obese adolescents with and without type 2 diabetes: impaired or intact? 
  • The influence of hyperglycemia on neutrophil extracellular trap formation and endothelial glycocalyx damage in a mouse model of type 2 diabetes. 
  • The liver in obesity and type 2 diabetes mellitus. 
  • The past, present, and future physiology and pharmacology of glucagon. 
  • The pathogenesis of insulin resistance in children: metabolic complications and the roles of diet, exercise and pharmacotherapy in the prevention of type 2 diabetes. 
  • The polarizing effect of news media messages about the social determinants of health. 
  • The relation between platelet reactivity and glycemic control in diabetic patients with cardiovascular disease on maintenance aspirin and clopidogrel therapy. 
  • The relationship between Pittsburgh Sleep Quality Index subscales and diabetes control. 
  • The relationship between glycemic control and health-related quality of life in patients with non-insulin-dependent diabetes mellitus. 
  • The relationship of dietary fish intake to diabetic retinopathy and retinal vascular caliber in patients with type 2 diabetes. 
  • The relationship of insulin secretion and GAD65 antibody levels at diagnosis on glycemic control in type 2 diabetes. 
  • The relationship of retinal vessel caliber with erectile dysfunction in patients with type 2 diabetes. 
  • The role of GIP in α-cells and glucagon secretion. 
  • The role of acculturation in diabetes self-management among Chinese Americans with type 2 diabetes. 
  • The role of diabetes mellitus in the composition of coronary thrombi in patients presenting with acute ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention. 
  • The role of dysregulated glucagon secretion in type 2 diabetes. 
  • The use of bioactive glass S53P4 in the treatment of an infected Charcot foot: a case report. 
  • The use of electronic health records for recruitment in clinical trials: a mixed methods analysis of the Harmony Outcomes Electronic Health Record Ancillary Study. 
  • Theory of partitioning of disease prevalence and mortality in observational data. 
  • Thiazolidinediones and risk for atherosclerosis: pleiotropic effects of PPar gamma agonism. 
  • Thiazolidinediones, peripheral oedema and congestive heart failure: what is the evidence? 
  • Time-dependent event accumulation in a cardiovascular outcome trial of patients with type 2 diabetes and established atherosclerotic cardiovascular disease. 
  • Tirzepatide induces a thermogenic-like amino acid signature in brown adipose tissue. 
  • Tissue-specific alterations in G protein expression in genetic versus diet-induced models of non-insulin-dependent diabetes mellitus in the mouse. 
  • Tolerability and safety barriers to sodium-glucose cotransporter 2 inhibitor initiation in heart failure with reduced ejection fraction. 
  • Topical lineage-negative progenitor-cell therapy for diabetic wounds. 
  • Towards living guidelines on cardiorenal outcomes in diabetes: A pilot project of the Taskforce of the Guideline Workshop 2020. 
  • Trans-ethnic Meta-analysis and Functional Annotation Illuminates the Genetic Architecture of Fasting Glucose and Insulin. 
  • Transferability and fine-mapping of glucose and insulin quantitative trait loci across populations: CARe, the Candidate Gene Association Resource. 
  • Transferability of type 2 diabetes implicated loci in multi-ethnic cohorts from Southeast Asia. 
  • Translating the hemoglobin A1C with more easily understood feedback: a randomized controlled trial. 
  • Treatment disparities in the care of patients with and without diabetes presenting with non-ST-segment elevation acute coronary syndromes. 
  • Treatment of Type 2 diabetes mellitus in Chongqing of China: unaffordable care for the poor. 
  • Treatment preferences and medication adherence of people with Type 2 diabetes using oral glucose-lowering agents. 
  • Treatment with incretins does not increase the risk of pancreatic diseases compared to older anti-hyperglycaemic drugs, when added to metformin: real world evidence in people with Type 2 diabetes. 
  • Treatment with the dipeptidyl peptidase-4 inhibitor vildagliptin improves fasting islet-cell function in subjects with type 2 diabetes. 
  • Trends in all-cause and cardiovascular disease mortality among women and men with and without diabetes mellitus in the Framingham Heart Study, 1950 to 2005. 
  • Trends in cardiovascular disease risk factors in individuals with and without diabetes mellitus in the Framingham Heart Study. 
  • Trends in cardiovascular risk factors and treatment goals in patients with diabetes in Singapore-analysis of the SingHealth Diabetes Registry. 
  • Trends in diabetes incidence: the Framingham Heart Study. 
  • Trends in the incidence of type 2 diabetes mellitus from the 1970s to the 1990s: the Framingham Heart Study. 
  • Tubular markers are associated with decline in kidney function in proteinuric type 2 diabetic patients. 
  • Twenty years after ACEIs and ARBs: emerging treatment strategies for diabetic nephropathy. 
  • Two diets with different haemoglobin A1c and antiglycaemic medication effects despite similar weight loss in type 2 diabetes. 
  • Type 2 (non-insulin-dependent) diabetes mellitus, migration and westernisation: the Tokelau Island Migrant Study. 
  • Type 2 Diabetes Education and Support in a Virtual Environment: A Secondary Analysis of Synchronously Exchanged Social Interaction and Support. 
  • Type 2 Diabetes Genetic Variants and Risk of Diabetic Retinopathy. 
  • Type 2 Diabetes Mellitus and Heart Failure, A Scientific Statement From the American Heart Association and Heart Failure Society of America. 
  • Type 2 Diabetes Mellitus and Heart Failure: A Scientific Statement From the American Heart Association and the Heart Failure Society of America: This statement does not represent an update of the 2017 ACC/AHA/HFSA heart failure guideline update. 
  • Type 2 Diabetes Variants Disrupt Function of SLC16A11 through Two Distinct Mechanisms. 
  • Type 2 Diabetes and Atherosclerotic Cardiovascular Disease in South Asians: a Unique Population with a Growing Challenge. 
  • Type 2 diabetes and insulin resistance: an hepatocentric phenomenon? 
  • Type 2 diabetes mellitus, brain atrophy, and cognitive decline. 
  • Type 2 diabetes, thiazolidinediones: bad to the bone? 
  • Type 2 diabetes: evidence for linkage on chromosome 20 in 716 Finnish affected sib pairs. 
  • UDP-N-acetylglucosamine transferase and glutamine: fructose 6-phosphate amidotransferase activities in insulin-sensitive tissues. 
  • Underexpression of beta cell high Km glucose transporters in noninsulin-dependent diabetes. 
  • Understanding of basic mechanisms of beta-cell function and survival: prelude to new diabetes therapies. 
  • Understanding the type 2 diabetes mellitus and cardiovascular disease risk paradox. 
  • Update on type 2 diabetes mellitus: understanding changes in the diabetes treatment paradigm. 
  • Updated risk factors should be used to predict development of diabetes. 
  • Urinary Angiotensinogen Could Be a Prognostic Marker of Renoprotective Effects of Alogliptin in Patients with Type 2 Diabetes. 
  • Urinary F2-isoprostanes and metabolic markers of fat oxidation. 
  • Urinary F2-isoprostanes and the risk of hypertension. 
  • Urinary F2-isoprostanes are not associated with increased risk of type 2 diabetes. 
  • Urinary F2-isoprostanes as a biomarker of reduced risk of type 2 diabetes. 
  • Urinary F2-isoprostanes, obesity, and weight gain in the IRAS cohort. 
  • Use of Lipid-, Blood Pressure-, and Glucose-Lowering Pharmacotherapy in Patients With Type 2 Diabetes and Atherosclerotic Cardiovascular Disease. 
  • Use of an insulin bolus advisor facilitates earlier and more frequent changes in insulin therapy parameters in suboptimally controlled patients with diabetes treated with multiple daily insulin injection therapy: results of the ABACUS trial. 
  • Use of an insulin bolus advisor improves glycemic control in multiple daily insulin injection (MDI) therapy patients with suboptimal glycemic control: first results from the ABACUS trial. 
  • Use of combination antihypertensive therapy initiation in older Americans without prevalent cardiovascular disease. 
  • Usefulness of diabetic retinopathy as a marker of risk for thallium myocardial perfusion defects in non-insulin-dependent diabetes mellitus. 
  • Using a low-carbohydrate diet to treat obesity and type 2 diabetes mellitus. 
  • Using electronic health record data for substance use Screening, Brief Intervention, and Referral to Treatment among adults with type 2 diabetes: Design of a National Drug Abuse Treatment Clinical Trials Network study. 
  • Utility of hemoglobin A1c in predicting diabetes risk. 
  • Validation of the WATCH-DM and TRS-HFDM Risk Scores to Predict the Risk of Incident Hospitalization for Heart Failure Among Adults With Type 2 Diabetes: A Multicohort Analysis. 
  • Variability in sleep disturbance, physical activity and quality of life by level of depressive symptoms in women with Type 2 diabetes. 
  • Variation in Postpartum Glycemic Screening in Women With a History of Gestational Diabetes Mellitus. 
  • Variation in glucose homeostasis traits associated with P2RX7 polymorphisms in mice and humans. 
  • Veterans' Interpretation of Diabetes Distress in Diabetes Self-Management: Findings From Cognitive Interviews. 
  • Viral Infection "Interferes" with Glucose Tolerance. 
  • Vitamin D Supplementation and Prevention of Type 2 Diabetes. 
  • Vitamin D status of black and white Americans and changes in vitamin D metabolites after varied doses of vitamin D supplementation. 
  • Vitamin D supplementation for prevention of cancer: The D2d cancer outcomes (D2dCA) study. 
  • Weight and Metabolic Outcomes 12 Years after Gastric Bypass. 
  • Weight and mortality in adults with diabetes. 
  • Weight change in patients with type 2 diabetes starting basal insulin therapy: correlates and impact on outcomes. 
  • What is the price of life and why doesn't it increase at the rate of inflation? 
  • When do patients and their physicians agree on diabetes treatment goals and strategies, and what difference does it make? 
  • Wide clinic-level variation in adherence to oral diabetes medications in the VA. 
  • Within-Trial Evaluation of Medical Resources, Costs, and Quality of Life Among Patients With Type 2 Diabetes Participating in the Exenatide Study of Cardiovascular Event Lowering (EXSCEL). 
  • β-Cell Function Over Time in Adolescents With New Type 2 Diabetes and Obese Adolescents Without Diabetes. 
  • β-cell dysfunction in adolescents and adults with newly diagnosed type 2 diabetes mellitus. 
• 

  Keywords of People

  • Abbruzzese, James, D. C. I. Distinguished Professor of Medical Oncology, Medicine, Medical Oncology
  • Adkins, Deanna Wilson, Associate Professor of Pediatrics, Pediatrics, Endocrinology
  • Alexander, John Hunter Peel, Professor of Medicine, Medicine, Cardiology
  • Alexopoulos, Anastasia Stefania, Assistant Professor of Medicine, Medicine, Endocrinology, Metabolism, and Nutrition
  • Allori, Alexander C, Associate Professor of Surgery, Surgery, Plastic, Maxillofacial, and Oral Surgery
  • Bennett, Vann, George Barth Geller Distinguished Professor of Molecular Biology, Duke Cancer Institute
  • Cho, Alex Han, Associate Professor of Medicine, Medicine, General Internal Medicine
  • Farsiu, Sina, Professor in the Department of Biomedical Engineering, Electrical and Computer Engineering
  • Freemark, Michael Scott, Robert C. Atkins, M.D. and Veronica Atkins Distinguished Professor of Pediatrics, in the School of Medicine, Pediatrics, Endocrinology
  • Georgiades, Anastasia, Research Scientist, Psychology & Neuroscience
  • Grimsrud, Paul, Assistant Professor in Medicine, Medicine, Endocrinology, Metabolism, and Nutrition
  • Hilton, Matthew James, Associate Professor in Orthopaedic Surgery, Cell Biology
  • Hirschey, Matthew, Associate Professor of Medicine, Cell Biology
  • Hoffman, Maureane, Professor of Pathology, Integrative Immunobiology
  • Humphreys, Margaret Ellen, Josiah Charles Trent Distinguished Professor of the History of Medicine, in the School of Medicine, Duke Science & Society
  • Lewinski, Allison A., Assistant Research Professor in the School of Nursing, School of Nursing
  • O'Connor, Christopher Michael, Adjunct Professor in the Department of Medicine, Medicine, Clinical Pharmacology
  • Ostbye, Truls, Professor of Family Medicine and Community Health, Family Medicine and Community Health
  • Pang, Herbert, Adjunct Assistant Professor in the Department of Biostatistics & Bioinformatics, Biostatistics & Bioinformatics
  • Patel, Uptal Dinesh, Adjunct Professor in the Department of Medicine, Medicine, Nephrology
  • Preminger, Glenn Michael, James F. Glenn, M.D. Distinguished Professor of Urology, Surgery, Urology
  • Yancy Jr., William Samuel, Professor of Medicine, Medicine, General Internal Medicine
  • Zullig, Leah L, Professor in Population Health Sciences, Medicine, General Internal Medicine